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A healthy and stable gastrointestinal microbiota is a vital feature of the innate immune 
system.  It affords the host numerous health benefits and acts as a barrier against 
opportunistic gut infections.  Probiotic bacterial supplements are, therefore, widely used in 
industry to promote good health.  There is, however, a need to understand not only the factors 
underlying the health promoting capabilities of these bacteria, but also the intrinsic 
antimicrobial resistance mechanisms which these bacteria are known to harbour.  These 
antibiotic resistance traits confer a competitive advantage on these bacteria over other 
bacterial species where they reside in the gut.  It also allows them to survive during antibiotic 
therapy and they are able to continue conferring health benefits on the host. 
To better understand the mechanisms these bacteria utilize in conferring antibiotic resistance, 
genes which confer multidrug resistance by the active hydrolysis of ATP were studied here.  
These genes belong to the ATP-binding cassette (ABC) family of efflux transporters.  ABC-
type transporter genes in other bacteria have previously been shown to confer multidrug 
resistance to numerous antimicrobial substances.  Bioinformatic analysis of the genome of 
Bifidobacterium longum subsp. longumT JCM 1217 highlighted the presence of two gene 
clusters containing two ABC-type transporter genes each, as well as, a putative 
transcriptional regulator upstream of the structural genes.  Reverse transcriptase analysis of 
these two gene clusters indicated they were arranged in two operons, one comprising three 
genes, inclusive of the putative regulator and the other comprising two ABC-type transporter 
genes, excluding the adjacent putative regulator.  Cloning and heterologous expression of 
these genes showed that they were able to confer a multidrug resistance phenotype on the 
host Lactococcus lactis cells.  An increase in the minimum inhibitory concentration of 
between 1.5 – 3 folds to both erythromycin and tetracycline, both of which are known 
substrates of ABC-type transporters, was observed.  Efflux assays, using the substrate 
Hoechst 33342, gave an indication of the ATP-dependence of these transporters, but, due to 
the high background efflux activity of the host cells, no definitive conclusions could be made. 
Experiments, using multiplex Real Time PCR, were conducted to quantify the gene 
transcription levels of these transporter genes in B. longum cells which had been exposed to 
erythromycin as compared to the levels of gene expression of cells grown under normal 
growth conditions.  The results indicated an increase in the levels of gene expression for the 















genes in the three gene operon, the increase in transcription was shown to be statistically 
significant. 
The presence of the putative transcriptional regulators upstream of both operons was 
intriguing, since it had previously been shown, in other bacteria, that transcriptional 
regulators belonging to the MarR family of regulators are able to repress the expression of 
ABC-type transporter genes under normal growth conditions.  Bioinformatic analysis of the 
two putative regulators in this study showed that the structure of the regulator in the three 
gene operon, of which it is part, most closely resembled that of other proven MarR-type 
regulators.  To evaluate the role of these putative regulators with respect to the ABC-type 
transporter genes down-stream of them, electrophoretic mobility shift assays (EMSA) were 
carried out.  The putative regulator genes were cloned, expressed and their proteins purified.   
The results of the EMSA experiments showed that the putative MarR-type regulator protein, 
upstream of the three gene operon of which it is part, bound stably, specifically and with high 
affinity to the DNA sequence directly upstream of the operon.  Binding of this regulator 
protein was not easily de-repressed even in the presence of known inhibitors such as sodium 
salicylate and it did not bind to other DNA sequences even when presented with a proven 
promoter region or the upstream DNA sequence of the other operon being studied.  No such 
binding was observed for the second putative regulator, which showed no significant 
similarity to other MarR-type regulators and was not a part of the operon downstream of it. 
 
The data obtained in this study showed the occurrence of functional ABC-type transporter 
genes in a probiotic bacterium, and demonstrated that their genome arrangement facilitated 
simultaneous transcription of these genes.  The transcriptional induction of these genes in 
response to erythromycin exposure was confirmed and the first functional evidence was 
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1.1. The gastrointestinal tract 
The gastrointestinal tract (GIT) of all animals is known to house a vast and intricate micro-
ecosystem of distinct complexity (Holzapfel & Schillinger, 2002).  Its mucous covered 
surface encompasses an area estimated to be approximately 150 – 200 m2, which when 
compared to the surface area of the skin covering the entire human body (2 m2) is rather vast 
(Waldeck, 1990).  The immense surface area available thus enables the immense resident and 
transient microbiota to adhere to and interact with the host and aids the process of digestion 
(Holzapfel & Schillinger, 2002).  It is estimated that the adult human GIT is colonised with 
approximately 1014 microbes.  This implies an important role by these organisms when it is 
taken into account that there are approximately 1013 tissue cells in the entire human body 
(Ley et al., 2006; Luckey, 1972). 
The immense diversity of the GIT differs from one region to the next and its composition is 
determined by both intrinsic and extrinsic factors such as diet and the physical condition of 
the host (Holzapfel & Schillinger, 2002).  The resident or autochthonous microbiota residing 
in the GIT has been shown to encompass more than 400 species in diverse bacterial genera.  
These include Gram positive bacteria, most of which are obligate anaerobes, and which 
predominate in the large intestine, for example Eubacterium and Bifidobacterium spp.  Gram 
negative organisms also flourish in this niche, for example; large numbers of Escherichia 
coli, Bacteroides and members of the Enterobacteriaceae are present (Holzapfel & 
Schillinger, 2002) (Figure 1.1). 
 















The profile of strains of Bifidobacterium and Lactobacillus residing in a host has been shown 
to be both unique for every individual (Tannock, 1997), and that the human GIT microbiota 
differs considerably from that of other mammals (Akkerman et al., 2000).  Recent studies 
using metagenomic approaches to assess the human gut microbiome has shown that even 
though bacterial profiles may be unique for every individual, the bacterial species present in 
the human gut and the numbers thereof are largely shared among individuals.  These studies 
also indicate that the major evolutionary driving forces of the diversity of these microbiomes 
may be as a result of the conditions in the gut as well as human-microbe interactions (Ley et 
al., 2006; Qin et al., 2010).  In the past, little emphasis was placed on the GIT and its resident 
microbiota since most of the scientific focus was centred on enteropathogens and their 
pathogenesis leading to dysbiosis.  It is now recognised that a healthy and stable GIT 
microbiota affords a sturdy barrier against any would-be invading pathogens or harmful 
substances (Holzapfel & Schillinger, 2002).  Holzapfel et al., (1998) defined the major 
functions of the autochthonous biota of the human GIT as barrier function or restoration, 
immune system stimulation, maintenance of mucosa, nutrition and circulation, production of 
nutrients and improved bioavailability and the stimulation of bowel motility. 
 
1.2. Colonization and succession 
While in the mothers’ womb, the developing foetus is maintained in a sterile environment 
and is thus kept in an aseptic condition since all nutrient metabolism and excretory functions 
are performed by the mother.  It is only during labour that the foetus is, for the first time, 
exposed to microorganisms.  Colonization commences upon contact with the resident bacteria 
in the birth canal of the mother and subsequently from the surrounding environment.  It has 
been observed that the diet of the baby from this point onwards drastically affects the 
development of the GIT micro-ecosystem (Palmer et al., 2007).  Both breast fed and formula 
fed babies seemingly start with the same colonising organisms, i.e. Escherichia coli and 
Streptococcus predominating.  In breast fed babies succession then occurs with a prominent 
increase in Bifidobacterium numbers, coinciding with a decrease in E. coli and Streptococcus 
numbers, with Clostridium almost never observed (Figure 1.2).  It has also been shown that 
certain Bifidobacterium sp. are present in breast milk and are passed from mother to the baby 
during breast feeding (Gueimonde et al., 2006).  16S rRNA and metagenomic studies are 
















Figure 1.2. Changes in the intestinal microbiota with age (Mitsuoka, 1978). 
The situation in formula fed babies is, however, completely different with almost no 
succession being observed.  There are high numbers of Bacteroides, Clostridium and 
Streptococcus species present, and even though Bifidobacterium is found, it is not dominant.  
When supplements, e.g. iron, are introduced into the diets of breast fed babies, the developing 
GIT biota resembles that of the formula fed infant, with Bacteroides and Gram positive cocci 
predominating.  Once both groups are weaned, the adult GIT microbiota develops, with a 
decrease in Streptococcus and E. coli numbers (Bullen et al., 1977; Mevissen-Verhage et al., 
1985).  Stabilization of the final GIT micro-ecosystem is controlled by the host’s immune 
system and the internal physiology of the GIT itself.  These factors cooperatively prevent 
over or unregulated growth and will determine the final micro-ecosystem.  Factors such as 
pH, enzymes, bile, synergy v/s antagonism and diet, will thus all play a role in determining 
the final micro-ecosystem of each individual (Koenig et al., 2010; Mitsuoka, 1990; Mitsuoka, 
1992), which has been shown to be unique to every individual (Tannock, 1997).  Even though 
the micro-ecosystem of individuals appears to be unique, recent metagenomic studies have 
shown the occurrence of three so-called ‘enterotypes’.  These enterotypes identify certain 
conserved microbial profiles in the gut which are not explained by host properties such as 
gender, age or weight.  Marker genes relating to these host properties are present and can 
therefore potentially be used in diagnostics (Arumugam et al., 2011).  The question, 
therefore, arises whether to supplement the diet of individuals, who may be pre-disposed to 
gut disorders, with these health promoting bacteria?  For this reason it is necessary that 
research be conducted to ensure that safe, effective and stable probiotic bacterial supplements 
are available as treatments to allow for the development of a normal, healthy and beneficial 















2. The role of probiotics 
2.1. Background and definition 
Even though probiotic bacteria encompass a large group of bacterial strains, the important 
role played by the lactic acid bacteria (LAB) is of predominant interest.  As early as 1892, it 
was suggested that LAB play a beneficial role within the human host (Döderlein, 1892).  The 
origin of the term “probiotic” is believed to have been coined in 1954, in a paper studying the 
effects of antimicrobials and factors favourable to the gut microbiota, and is derived from 
Greek, meaning “for life” (Vergio, 1954).  One of the current accepted definitions of a 
probiotic bacterium is that it refers to ‘Viable microorganisms that promote or support a 
beneficial balance of the autochthonous microbial population of the GIT’ (Holzapfel et al., 
2001; Holzapfel et al., 1998). 
 
2.2. Characterisation of probiotics 
Even though probiotics are known to benefit the host, the scientific data to confirm this is still 
insufficient to provide conclusive proof of their role and involvement in conferring these 
health benefits.  The actual mechanisms underlying the effects observed when probiotic 
supplements are consumed thus need to be further elucidated.  The World Health 
Organisation (WHO) and the United Nations Food and Agriculture Organisation (UNFAO) 
have, however, agreed that there is sufficient data to conclude that probiotics do in fact 
improve human health, and that certain strains are safe for commercial use (UNFAO & 
WHO, 2001). 
In order for a new strain of bacteria to be considered for use as a potential probiotic 
supplement, there are certain aspects which first need to be evaluated, tested and confirmed 
before its use can be safely justified.  The WHO and FAO have thus formed guidelines for 
the evaluation of potential probiotic strains.  These include: strain identification to species 
level, using reliable molecular techniques; in vitro and in vivo studies to confirm the 
physiological properties of the strain, such as adhesion and pathogen inhibition capabilities; 
safety assessment of the strain, especially in immunocompromised patients where 
septicaemia may occur; phase 2 clinical trials, to compare the efficacy of the probiotic in 















probiotic to that of a current treatment of the same type; and finally, accurate health claims 
and labelling of the new product to inform the consumer of the actual proven health benefits 
(UNFAO & WHO, 2002). 
For the effective use of probiotics in industry, they must possess certain features to ensure the 
best possible results for the manufacturer and consumer.  There are, therefore, three main 
characteristics which are considered desirable for a probiotic bacterium.  They should be non-
pathogenic, able to survive the hosts’ immune response and be genetically stable.  They 
should be culturable in large scale applications for industrial processing of the final product.  
They should offer numerous beneficial properties in vivo (Havenaar et al., 1992). 
One of the most valuable contributions conferred by the presence of these organisms in the 
GIT is the competitive exclusion of pathogenic organisms.  It has been proven that certain 
strains of Bifidobacterium are able to bind to the surfaces of most regions in the intestines 
where they reside, as a result of their hydrophobicity profiles and autoaggregative properties 
(Bibiloni et al., 2001; Del Re et al., 2000).  In so doing they are proposed to reinforce the 
GIT barrier, thus preventing the binding of pathogenic organisms.  They have also been 
shown to secrete a protein which inhibits the binding of certain pathogens such as 
enterotoxigenic E. coli (Fujiwara et al., 1997).  Other antimicrobial substances are also 
known to be produced by certain strains of Lactococcus lactis (nisin) and Bifidobacterium, 
and when coupled with the secretion of lactic acid by these bacteria and the subsequent 
lowering of the surrounding pH, the outer membrane of Gram negative cells is significantly 
weakened, thus potentiating the effect of these and other antimicrobial substances present 
(Alakomi et al., 2000; Liévin et al., 2000; Mierau & Kleerebezem, 2005).  The most 
noticeable pathogen exclusion model is, however, the exclusion of these organisms by 
competitive binding to enterocyte cell surface receptors for attachment or stearic hindrance, 
as was demonstrated with Lactobacillus species (Chan et al., 1985).  The pathogen inhibiting 
properties of lactic acid bacteria once again strengthens the case for their use in the 
pharmaceutical industry, as their health promoting activity seems to outweigh their potential 
negative properties. 
2.3. Prebiotics and synbiotics 
The term ‘prebiotic’ is alleged to have been coined in 1995 and was defined as “A non-















growth and/or activity of one or a limited number of bacteria in the colon” (Gibson & 
Roberfroid, 1995).  These substances include indigestible but fermentable sugars, usually 
short chain carbohydrates (SSC) or low-digestible carbohydrates, which stimulate the growth 
of certain bacterial groups.  These prebiotic substances are generally shown to increase sugar 
digestion and absorption in the bowel, affect glucose and lipid metabolism and protect against 
certain risk factors of cardiovascular disease.  They also produce short-chain fatty acids in the 
colon which is considered to be a factor in the prevention of colorectal cancer (Scheppach et 
al., 2001). 
When a probiotic bacterium and a prebiotic substrate are combined in a single product or 
supplement the term ‘synbiotic’ is applied.  Since the term alludes to synergism, it should be 
reserved for situations where the prebiotic substrate favours the growth of the probiotic 
bacterium it is combined with (Schrezenmeir & de Vrese, 2001).  Synbiotics can be 
specifically designed to affect or target an isolated region of the GIT or even more than one 
region (Holzapfel & Schillinger, 2002).  It has been proven that a synbiotic can confer 
benefits to the host which are above that of either one on its own (Rowland et al., 1998). 
 
3. Bifidobacteria 
3.1. Background and morphology 
Bifidobacteria are human gut commensals and can be regularly isolated from the GIT of 
humans and animals.  They play a major role in maintaining the homeostatic balance required 
in the GIT.  They are obligate anaerobes, and are classified as high G+C Gram positive 
bacteria in the Actinomycetales branch, grouping them with the Corynebacteria, 
Mycobacteria, and Streptomycetes.  Even though most of the approximately 32 species of 
Bifidobacterium identified to date are isolated from the GIT, a small number are found in the 
human vagina and oral cavity as normal flora in healthy individuals and recent studies using 
non-culture dependent techniques have identified new species in the GIT which were 
previously not isolated (Biavati & Mattarelli, 2001; Turroni et al., 2009).  The morphology of 
bifidobacteria were described in 1889 as being “curved rods and rods with ends split to give 
the characteristic Y-shape which led to the designation of ‘bifid’” (Tissier, 1889).  They were 
subsequently further characterised as non-motile, non-spore forming rods which may vary in 















researchers’ found that in media rich in the necessary nutrients, bifidobacteria occur as 
curved or clubbed shaped, uniform or branched, bifurcated Y and V forms, and may also be 
spatulate.  In nutrient limited media, the cells are highly pleomorphic and branched, but are 
mostly rod shaped in their natural environment. 
3.2. Growth requirements 
The bifidobacteria are classified as obligate anaerobes  (Scardovi, 1984), but a few species 
are able to tolerate oxygen (Simpson et al., 2004).  The optimum growth temperature of 
human isolates of bifidobacteria is between 36 – 38°C, and that of animal strains, between 41 
– 43°C, but, can be as high as 49.5°C for the thermophile Bifidobacterium 
thermoacidophilum or as low as 4°C for Bifidobacterium psychraeophilum (Dong et al., 
2000; Simpson et al., 2004).  Bifidobacteria are considered to be acid tolerant microbes and 
have an optimum growth pH of between 6.5 and 7.0.  Some strains can grow at a pH of 3.5 
(Matsumoto et al., 2004) but none survive if cultured at pH 8.5 or above (Biavati et al., 
2000). 
Due to the similar niche occupied by bifidobacteria and lactobacilli, a semi-synthetic 
supplemented growth medium, which stimulates the growth of lactobacilli, was initially used 
to culture bifidobacteria (Norris et al., 1950).  It was however only in 1951, when studies on  
the properties of the medium above showed that a simple medium, supplemented with 
cysteine, could support the growth of bifidobacteria, as they would utilise ammonium salts as 
a source of nitrogen (Hassinen et al., 1954).  It is only Bifidobacterium bifidum that requires 
the further addition of N-acetyl-D-glucosamine-containing saccharides, which facilitate cell 
wall synthesis (Glick et al., 1960; O'Brien et al., 1960). 
3.3. Classification 
Most Gram positive, non-spore forming, branched or unbranched rods, not yet classified in 
the early 1900’s, were initially assigned to the genus Bacillus and then subsequently to the 
genus Lactobacillus.  Because of this, references to Gram positive rods in earlier literature 
could have referred to a number of different genera recognised today as separate (Poupard et 
al., 1973).  Tissier’s description in 1899 – 1900, of irregular, Gram positive, Y-shaped, non-
gas producing, anaerobic bacteria, which may be bifurcated, isolated from the stools of 
breast-fed babies, as B. bifidum, marked an initial endeavour to classify these organisms.  The 















fact be classified in its own genus which he designated as Bifidobacterium (Orla-Jensen, 
1924).  This is currently the accepted nomenclature for members of this family.   
Today the genus is represented by approximately 37 species, isolated mainly from the GIT’s 
of humans and animals (Turroni et al., 2011).  The genus is anchored in the branch of 
Actinomycetales encompassing the high G+C Gram positive bacteria (Klein et al., 1998). 
 
4. Antibiotics and resistance 
4.1. Background 
With the advent of antibiotics in the 1940s, it was believed that bacterial infections and 
mortalities due to such infections were to become a thing of the past and focus was thus 
aimed at researching new and more complex diseases.  This was, however, not the case.  
Instead of the expected decline in the incidence of bacterial infections and the successful 
treatment thereof, incidences of infection due to resistance to the current therapies increased 
readily and drug resistance is now a major concern.  It is only recently that the reasons for 
antimicrobial resistance to these compounds have been researched and scientists in this field 
now know that bacteria have always been faced with unfavourable conditions and exposure 
to toxic compounds in their natural environments.  This has consequently lead to the 
development of mechanisms, by these organisms, to counteract the negative effects of these 
molecules (Salyers & Amábile-Cuevas, 1997).  These ancient resistance mechanisms may be 
the underlying cellular machinery, which bacteria have adapted to become resistant to 
modern antimicrobials. 
4.2. Mechanisms 
Bacteria have evolved numerous mechanisms which they use to prevent the damage inflicted 
by exposure to antimicrobial and toxic substances.  All of these mechanisms can be grouped 
into four basic systems (Figure 1.3); drug inactivation, target alteration, inhibition of drug 
influx and active extrusion of these compounds from the inside to the outside (Putman et al., 
2000).  Research focus in the past was mainly on the first three mechanisms listed, as these 
were likely targets for the development of new generations of antibiotic compounds.  It is 
now, however, realised that bacteria have the ability to develop resistance mechanisms to 
















Figure 1.3. The four antimicrobial resistance mechanisms in bacteria. (A) Drug inactivation, (B) target alteration, (C) inhibition of influx, 
and (D) extrusion (Putman et al., 2000). 
Since drug efflux mechanisms in bacteria allow them to prevent the entry of toxic molecules 
into the cell, as well as, the occurrence of multidrug efflux transporters, drug extrusion 
systems have become a focus of antimicrobial research (Borges-Walmsley et al., 2003).  The 
first three mechanisms above, i.e. inactivation, alteration and preventing influx, are limited in 
their efficacy and range as they are often specific for the relevant substrates they act on or 
against.  The active extrusion of toxic compounds, facilitated by efflux pumps, is not limited 
in this respect.  Even though substrate specific pumps abound in bacteria, there are a large 
number of multidrug transporters that are able to actively efflux a vast number of unrelated 
antimicrobial compounds (Borges-Walmsley et al., 2003).  This mechanism of multidrug 
resistance, conferred by a single protein, is only now being studied in much greater detail. 
 
4.3. Resistance mechanisms in Bifidobacterium 
Probiotic bacteria such as Bifidobacterium confer health benefits on the host and are not 
considered to be pathogenic under normal conditions – both of which are criteria for their 
selection as probiotics.  It is, therefore, not a concern that these bacteria are in fact 
intrinsically resistant to numerous antimicrobial compounds which are routinely administered 
as treatments for disease conditions.  Even though the presence of efflux proteins in these 
bacteria is alarming and may indicate that organisms harbouring such systems should be 
avoided, the presence of these systems in non-pathogenic organisms, especially probiotic 
organisms is largely ignored.   When this is coupled with the lack of understanding on the 
underlying mechanisms of resistance, it may appear safe to use these bacteria as probiotic 















4.4. Gene transfer 
If these probiotic strains do in fact pose no risk to the human host directly, the question 
regarding the possibility of the dissemination of these multidrug resistance genes via 
horizontal gene transfer to other potential pathogens in the GIT cannot be ignored (Figure 
1.4).  These genes would allow opportunistic pathogens to become hardy colonisers and 
extremely difficult to control, or even more dangerous, pathogenic strains may become 
completely untreatable.  The topic of horizontal gene transfer (HGT), (transfer of genetic 
material from one organism to another) is considered a common occurrence in bacteria, due 
to the current profusion of phylogenetic information available due to the sequencing of entire 
genomes.  This abundance of information has highlighted the presence of more and more 
homologous genetic material in unrelated species, which does not appear to be a part of the 
hosts’ original genome.  Because of this, geneticists and phylogeneticists agree that HGT is in 
fact widespread amongst prokaryotes and has been occurring for many years, and is believed 





Figure 1.4. Schematic representation of possible resistance gene transfer mechanisms (Salyers et al., 2004). 
In order for a gene to be transferred from one organism to another, a transfer mechanism is 
needed.  There are three generally excepted methods for HGT to occur in nature, namely: 
transformation (uptake of DNA from the surrounding environment), transduction (transfer of 
DNA from one cell to another using a bacteriophage) and conjugation (the transfer of DNA 
from one organism to another using a pilus).  Each of these mechanisms has its drawbacks, 
such as a narrow host range, the presence of DNA degrading enzymes and the need for 
sequence homology for integration, but, it appears that nature always seems to find a way, 
especially if sufficient selective pressure is applied and the cells are forced to adapt or die. 
It has been shown that antibiotic resistance genes transferred from Gram positive bacteria via 















observed.  Because of this, Gram negative cells are able to access the diverse genetic pool of 
Gram positive organisms.  Even though most plasmids of Gram positive origin are known to 
be unstable when expressed in Gram negative cells, conjugation is known to occur and the 
evidence of plasmids of Gram positive origin are still isolated from Gram negative 
organisms, as is the case with the transfer of the ermB gene from Enterococcus faecalis to E. 
coli in the human GIT (Arthur et al., 1987). 
Another mechanism often overlooked is that of transposition.  In 1991 it was proven that a 
conjugative transposon could in fact be transferred from Gram positive to Gram negative 
bacteria (Bertram et al., 1991).  Since transposons are able to integrate into the hosts’ 
genome, the question of plasmid instability is no longer a problem.  Once integrated, the 
genetic material is subsequently replicated and transferred to all the progeny of this mother 
cell. 
This concept of HGT is quite alarming when one considers the vast numbers of bacteria 
residing in the human GIT.  Of all the colonized areas in and on the body, the human GIT is 
one of the richest and most diverse, and also plays host to the vast numbers of transient 
bacteria which inadvertently pass through the system.  The concept that a reservoir of 
antibiotic genes found in the micro-ecosystem of the human GIT, which is shared among 
members of this niche and its transient microbiota, is thus not that farfetched (Simonsen et 
al., 1998; Teuber et al., 1999; Van Den Braak et al., 1998).  Evidence of this transfer is 
becoming abundant, with specific emphasis on the transfer of resistance genes between Gram 
positive and Gram negative bacteria in the human GIT (Figure 1.5). 
 















It is not surprising that Bifidobacterium spp. are included in the Figure above.  These bacteria 
are a dominant species in the infant GIT, are present in large numbers in the adult GIT and 
are common probiotic cultures.  They have also been shown to harbour the tetM gene (Aires 
& Butel, 2007).  It would, therefore, be unlikely that they did not participate in this exchange 
of genetic material.  Research is, however, still lacking in this regard as the extent to which 
these organisms participate in this process is still unknown.  It is only recently been shown 
that strains of Bifidobacterium are capable of suppressing the transfer of certain antibiotic 
genes in vitro and in vivo.   However, it has also been shown that this effect is strain specific 
(Moubareck et al., 2007). 
It was believed that bifidobacteria did not harbour any plasmids since none were isolated 
from any strains.  Studies have now indicated the presence of plasmids in numerous strains of 
bifidobacteria including, Bifidobacterium asteroides, Bifidobacterium breve, Bifidobacterium 
globosum, Bifidobacterium indicum, Bifidobacterium pseudocatenulatum and 
Bifidobacterium longum; where B. longum is now most frequently found to harbour plasmids 
(Álvarez-Martín et al., 2007; Iwata & Morishita, 1989; Sgorbati et al., 1982).  It has also 
been shown that the plasmids in B. longum show evidence of molecular re-arrangements, 
indicating their ability to share genetic material with other bacteria (Lee & O’Sullivan, 2006). 
The need to understand the basis of efflux systems and gene transfer of these systems would 
therefore allow for the selection of safe probiotic bacterial strains, since strains which are 
known to be drug resistant and which carry such determinants on mobile transmissible 
elements can be avoided.  Strains which stably maintain these genes on the chromosome can 
then be preferentially used since they can survive antibiotic therapy and are highly unlikely to 
transfer these genes to other bacteria. 
 
5. Efflux transporters 
5.1. Background 
Efflux pumps are integrated membrane proteins which actively pump unwanted or toxic 
compounds out of the cell (Borges-Walmsley & Walmsley, 2001).  Since bacteria are 
believed to have evolved in a ‘primordial soup’, the cellular membrane must be a relatively 















cellular constituents of the bacterium and its surrounding environment.  In this way the cell 
would be protected from its harsh, unfavourable surroundings, and would also be allotted a 
region within which it could perform its cellular reactions in a closed and regulated system 
(Van Bambeke et al., 2000). 
These efflux transporter proteins form an integral constituent of bacterial cell membranes and 
based on sequence homology, it has been calculated that approximately 15 – 20% of the E. 
coli genome may encode this type of protein (Paulsen et al., 1998).  Even though efflux 
pumps are considered to be a major resistance mechanism, it must be noted that their activity 
is limited in terms of the levels of resistance they confer to the host.  Most efflux systems 
confer an increase of between 1 – 64 folds in the minimum inhibitory concentration (MIC) of 
any given organism to a particular compound (Lomovskaya et al., 1999; Mazzariol et al., 
2000).  It must also be noted that resistance to a specific compound may be due to more than 
a single factor.  For example, the intrinsic resistance of many organisms to a substrate may be 
dependent on the constitutive or induced expression of a single or numerous efflux pumps (Li 
et al., 1995).  The expression of numerous different pumps may indicate a high level of 
resistance to a specific compound, which is in fact targeted by all these expressed systems co-
operatively (Lee et al., 2000).  Efflux systems may also work in conjunction with other 
systems such as enzymes, to rid the cell of a toxic substance.  For example, a β-lactamase 
coupled with an efflux pump to protect the cell from β-lactam type drugs (Okamoto et al., 
2001).  Some efflux pumps are regulated by the binding of certain antimicrobials to gene 
regulators and can in this way be induced to efflux this and/or other antimicrobials (Roberts, 
1996).  Mutations to these regulators or their DNA-binding sites may result in the efflux 
system being constitutively over-expressed (Poole, 2000), and if this is part of a global 
regulation system it may result in the over-expression of a number of efflux systems 
simultaneously (George, 1996).  Currently the most startling observation is that these efflux 
proteins are readily exchanged and transferred, even amongst distantly related bacterial 
genera (Del Grosso et al., 2002). 
5.2. Efflux pumps in probiotic bacteria 
Probiotic bacteria such as Bifidobacterium and Lactobacillus have been shown to be 
intrinsically resistant to numerous antimicrobial compounds (Aimmo et al., 2007; Masco et 
al., 2006).  These resistance properties are considered beneficial when selecting commercial 















continue providing their beneficial roles in the GIT, they may also prevent secondary 
infections in the gut.  Some of these resistance profiles are conferred by the presence of drug-
specific resistance genes such as tetW/M/O, which confers resistance to only tetracycline 
(Aires & Butel, 2007).  The most interesting contribution to resistance in probiotic bacteria is, 
however, the presence of efflux transporters, since these transporters are known to confer 
multidrug resistance (MDR) phenotype on the host cell, where a single protein is able to 
simultaneously confer resistance to numerous structurally unrelated antimicrobial substrates.  
MDR transporters are ubiquitous in bacteria and have been identified in numerous probiotic 
bacteria such as L. lactis (Florez et al., 2006) and B. breve (Margolles et al., 2006).  By 
expressing the proteins, these bacteria are able to remain viable during antibiotic therapy with 
numerous different antibiotics. 
5.3. Classification of bacterial transporters 
Due to ubiquity of these transporters, coupled with a lack of detailed phylogenetic data, a 
classification system based on primarily functional relatedness has been proposed.  The 
classification of drug transporters is thus based primarily on three criteria: the energy source 
used for driving it, its preliminary phylogenetic data, and its substrate specificity.  It has been 
proposed that a four-digit code be used to classify such transporters.  In this system the first 
digit represents the mode of transport and energy source used to drive the efflux pump; the 
second and third digits, refer to its phylogeny; and the fourth digit the substrate specificity of 
the transporters (Paulsen et al., 1998). 
Bacterial drug transporters have, therefore, been broadly classified into five families.  These 
familial systems are classified based on the three primary criteria above, but include the 
criterion of the presence of certain conserved amino acid sequences within the genes in 
question (Table 1.1).  The five families are the major facilitator superfamily (MFS), the small 
multidrug resistance (SMR) family, the resistance-nodulation-cell division (RND) family, the 
multidrug and toxic compound extrusion (MATE) family and finally the ATP-binding 
cassette (ABC) family (Putman et al., 2000).  Together these families encompass all of the 
active efflux systems identified to date.  Despite the fact that these systems are grouped so 
closely to one another, they are in fact extremely diverse in both structure and function, and 
have evolved intriguing and diverse mechanisms to purge unwanted substances from the 















Table 1.1. Amino acid consensus sequences of the conserved motifs in the MFS, SMR, and RND families 
(Putman et al., 2000). 
 
a The motifs were identified by alignment of amino acid sequences. (x) any amino acid, (Capitalised) amino acid occurs in >70% of 
sequences, (lowercase) amino acid occurs in < 40%, [(x)] amino acid not always present. 
The five families are foremost separated from one another based on the energy source used to 
drive them, i.e. either a proton gradient or by the hydrolysis of ATP.  Subsequently, the two 
classes are then further divided into the five respective families differentiated by the presence 
of specific conserved amino acid sequences in the coding regions of the genes.  In this way, 
four of the five families are clearly distinguishable from one another.  The MATE family 
merely encompasses those transporters which do not fit into any of the other four families 
based on the classification criteria.  There may thus be several new families classified in the 
near future which may selectively include some of these transporters (Putman et al., 2000).  
Figure 1.6 outlines the current relationships of the multidrug transporters found primarily in 
















Figure 1.6. Concise description of efflux transporter classification. 
 
5.4. Secondary multidrug transporters 
This class of transporters includes the MFS, SMR, RND and MATE families.  These 
transporters share a common feature, i.e. they are energised by an ion gradient between the 
internal cellular milieu and the external environment surrounding the cell.  This gradient is 
usually formed by a differential concentration of Na+ or H+ ions between the inside and 
outside of the cell. 
5.4.1 The major facilitator superfamily (MFS) 
The MFS comprises a family made up of those transporters which have transmembrane 
proteins capable of symport, antiport and uniport of various compounds into and out of the 
cell.  These membrane proteins are able to transport substances such as sugars and antibiotics, 
and are found in both prokaryotes and higher eukaryotes (Marger & Saier, 1993).  Based on 
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those with 12 transmembrane segments (TMS) and those with 14 TMS’s.  This family 
contains transporters present in both Gram positive and Gram negative bacteria, e.g. Bcr in E. 
coli and Bmr in Bacillus subtilis (Paulsen & Skurray, 1993). 
5.4.2 The small multidrug resistance (SMR) family 
These transporters are some of the smallest proteins with efflux function isolated thus far.  
They are approximately 107 amino acids long and are presumed to be arranged in a four-
helix, antiparallel bundle which is tightly packed (Putman et al., 2000).  Because of the small 
size of these transporters, function would only be feasible if a multi-unit complex is formed.  
It is thus believed that the transporters found in the SMR family occur as homooligomeric 
complexes of the single units fused to one another to form a complete functional unit 
(Paulsen et al., 1995). 
5.4.3 The resistance-nodulation-cell division (RND) family 
These transporters are present only in Gram negative bacteria.  Since the Gram negative 
bacterial cell envelope is composed of a thin peptidoglycan layer, surrounded by a thick outer 
membrane, these transporters need to transport compounds across not just one, but in fact two 
membranes.  To facilitate this, these transporters make use of a membrane fusion protein as 
well as an outer membrane protein to transport substances out of the cell directly into the 
surrounding medium (Putman et al., 2000).  It has been proposed that these transporters are 
composed of 12 TMS with large loops occurring between segments 1 and 2, and 7 and 8 
(Paulsen et al., 1996).  The membrane fusion proteins are proposed to fuse the inner and 
outer membrane by using either a single N-terminal transmembrane segment and a C-
terminal periplasmic domain (Dinh et al., 1994), or they are able to form a channel between 
the two membranes, in the periplasmic space (Zgurskaya & Nikaido, 1999). 
5.4.4 The multidrug and toxic compound extrusion (MATE) family 
This family encompasses all the multidrug transporters identified to date which do not fit the 
classification criteria of any of the other families.  Initial comparative analysis of 30 
transporter proteins in this family alluded to a grouping of 3 clusters (Brown et al., 1999), 
but, more recent studies using a PSI-blast search have identified > 800 related sequences 
from all three kingdoms of life (Omote et al., 2006).  Phylogenetic analysis of this data has 















5.5 Primary multidrug transporters 
All of the transporters in this family are driven by the hydrolysis of ATP which supplies the 
energy for translocating substrates out of the cell.  All of the ATP-dependent transporters 
which have thus far been identified are members of the ABC superfamily (Higgins, 1992).   
5.5.1 The ATP-binding cassette (ABC) family 
The principal ABC-type MDR transporter identified in a LAB was isolated from L. lactis and 
the gene coding for it was subsequently designated lmrA (Bolhuis et al., 1994).  Since then, it 
has been noted in the quaternary amino acid structure, that members of this family of 
transporters comprise four distinct domains (Figure 1.7).  They have two hydrophobic 
membrane domains and two hydrophilic cytoplasmic domains.  The two hydrophobic 
membrane domains are composed of 6 α-helix transmembrane segments and are thought to 
form a one-way channel through the membrane.  The two hydrophilic cytoplasmic domains 
are exploited for ATP binding and hydrolysis and are thus referred to as the nucleotide 
binding domains (NBD).  These NBD’s contain the conserved sequences characteristic of this 
family, i.e. the Walker A, Walker B, and the ABC signature motifs’ (Hyde et al., 1990; 
Walker et al., 1982).  It has been established, that a single gene does, in most cases, code for 
all four of these domains, as is the case with the well-studied human P-glycoprotein 
genotype, which is coded for in the order TMD-NBD-TMD-NBD (Gottesman et al., 1996). 
 
Figure 1.7. Crystal structure of Sav1866 from Staphylococcus aureus (Dawson & Locher, 2006). (a) Structure viewed perpendicular to the 
cell membrane lipid bilayer (grey box) in two orientations at right angles to each other. ICL’s indicate intracellular loops. (b) Structure in the 
plane of the cell membrane showing the substrate translocation pathway from the intracellular (left) and extracellular (right) faces of the 















The LmrA protein isolated from L. lactis has been the model protein for research in this field.  
The protein is 590 amino acids in length and is a membrane protein containing the four 
conserved domains of ABC transporters.  This protein, LmrA, is confirmed to be homologous 
to each of the two halves of the human P-glycoprotein, but, is functional as a homodimer 
(Veen et al., 1996).  When LmrA is substituted for P-glycoprotein in human lung fibroblast 
cells, it is able to complement the function of the other, and thus proves that this type of 
transporter is conserved between prokaryotes and eukaryotes (van Veen et al., 2000).  ATP-
dependent transporters have also been isolated from Archaea (Haloferax volcanii), 
illustrating their ubiquity in nature (Kaidoh et al., 1996). 
 
5.6 Modes of transport 
Even though a great deal of research has been done on these multidrug resistance proteins, 
there still remains much controversy on the actual mode of action.  Questions regarding how 
they recognise and efflux such a vast array of unrelated compounds and how the molecules 
are actually transported out, are only now beginning to be answered.  Current research 
proposes three basic models, i.e. the hydrophobic vacuum cleaner model, the flippase model 
and the periplasmic vacuum cleaner model. 
In both the hydrophobic vacuum cleaner model and the flippase model, the efflux protein is 
proposed to bind to the substrate in the inner leaflet of the lipid bilayer, and it is then 
subsequently removed from the cell.  The difference in the two models being that in the 
hydrophobic vacuum cleaner model, the bound substrate is actively ‘sucked’ from the inner 
leaflet of the membrane and then expelled into the surrounding medium.  With the proposed 
flippase model, the bound substrate is merely thought to be ‘flipped’ from the inner leaflet to 
the outer leaflet and is then removed by diffusion into the external medium.  The variation 
regarding the proposed periplasmic vacuum cleaner model arises when applied to Gram 
negative organisms.  In this model, the substrate is once more expelled using the vacuum 
cleaner approach, but, substrates are now removed not only from the inner leaflet of the lipid 
bilayer but also from the periplasmic space between the inner and outer membranes in Gram 
negative cells, and may utilise the action of another protein to transport the substrate from the 















coli (Figure 1.8) (Fralick, 1996; Gottesman & Pastan, 1993; Higgins & Gottesman, 1992; 
Murakami et al., 2002; Murakami & Yamaguchi, 2003; Zheleznova et al., 2000). 
 
Figure 1.8. Schematic representations of the proposed mechanisms of efflux via ABC-type transporters. (a) efflux into the external medium 
using the vacuum model, or, (b) flipped into the outer membrane of the lipid bilayer using the flippase model (Langton et al., 2005). 
 
5.7 ABC-type multidrug efflux in lactic acid bacteria 
Numerous ABC-type multidrug efflux proteins have been discovered in probiotic bacteria 
which confer multidrug resistance phenotypes such as the Lactococcal lmrA and lmrCD 
genes and the horA system in Lactobacillus (Lubelski & Driessen, 2007).  These systems 
have also been identified in Bifidobacterium strains (Margolles et al., 2006). Recently the 
crystal structures of ABC-type transporters have been elucidated, such as Sav1866 from 
Staphylococcus aureus, which is homologous to lmrA in L. lactis (Dawson & Locher, 2006).  
These crystal structures have provided much needed insight into the arrangement of these 
membrane proteins, and have confirmed the nature of the half transporter and full transporter 
which comprises a homodimer of two protein molecules joined to form one transporter 
(Dawson & Locher, 2006; Pleban et al., 2004).  The crystal structures of the vitamin B12 
transporters ButCD and BtuF are now shedding light on the actual arrangement of the NBD’s 
and on the actual mechanism of ATP-binding and hydrolysis (Locher & Borths, 2004). 
5.8 Putative regulators 
Since MDR efflux transporters are not essential for bacterial growth under conditions where 















presence of toxic molecules is another intriguing research question.  The role of 
transcriptional regulators in controlling the expression of these genes in bacteria has been 
investigated and research has shown that regulators of bacterial MDR transporter genes 
belong to four main families, namely: AraC, MarR, MerR and TetR, which all possess the 
Helix-Turn-Helix (HTH) domain used for DNA-binding.  All four families are highly 
complex with varying and complicated regulatory mechanisms (Lubelski & Driessen, 2007).  
Of particular interest with regards to ABC-type MDR transporters is that of the negative 
transcriptional regulator MarR, since it is well characterised and is known to be one of the 
primary regulators of MDR transporters in E. coli.  Crystal structures have also recently 
become available for this protein and have shown the presence of the winged-Helix-Turn-
Helix (wHTH) domain, which is the characterising feature of this family of transcriptional 
regulators (Nichols et al., 2009).  These regulators are also known to auto-regulate their own 
transcription by binding to DNA sequences (two direct repeats) upstream of the coding gene 
(Alekshun & Levy, 1997; Nichols et al., 2009).  Since these regulators are known to play a 
role in regulating bacterial MDR transporters, further research into their occurrence in 
probiotic bacteria needs to be conducted. 
 
6. Project aims 
From the information presented here, it is clear that probiotic strains play a significant role in 
promoting good health, as well as, in maintaining homeostasis in the human GIT.  There is, 
however, a great deal of research needed to bridge the gap between the observed effects they 
produce and the elucidation of the molecular basis for this, as well as, the underlying 
mechanisms of drug resistance they harbour.  This study is thus aimed at characterising both 
structurally and functionally, two putative ABC-type multidrug efflux gene clusters, 
identified in a healthy human gut isolate of Bifidobacterium longum subsp. longumT JCM 
1217, to illustrate the ubiquity and importance of these systems in conferring multidrug 
antibiotic resistance to members of the prokaryotic kingdom.  This will be accomplished 
using three main experimental approaches: 
1. Bioinformatic analysis to identify genes of interest in the genome of Bifidobacterium 















genes will be heterologously expressed to observe any MDR function, as well as, the 
ATP-dependence of the transporters needed for active transport. 
 
2. Confirmation of the role of the ABC-type transporter genes using antibiotic induction 
studies.  This will be investigated by studying possibility of inducing an increase in 
resistance to certain antibiotics in B. longum by first pre-exposing the cells to that 
antibiotic.  Any observed induction in the levels of transcription of these ABC-type 
transporter genes will then be measured using RNA-hybridization and quantitative 
Real Time PCR analysis. 
 
3. Finally, the role of putative transcriptional regulators which may regulate these genes 
will be investigated using electrophoretic mobility shift assays.  This may indicate the 
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Bifidobacterium longum is a gut commensal in the human gastrointestinal tract.  In this 
environment it is able to confer certain health benefits on the host.  In order for this continued 
interaction the bacterium must bind to and colonise the gut.  The use of antibiotic treatments 
to treat bacterial infections often causes significant changes in the gut biota of humans’ since 
the beneficial bacteria are simultaneously eliminated in the process, and this may lead to 
secondary infections by opportunistic bacteria in the gut, which would otherwise not be able 
to bind to and colonise the gut.  Bifidobacteria are, however, intrinsically resistant to 
numerous antimicrobial substances and are therefore usually able to survive antibiotic 
therapy.  The mechanisms underlying this innate resistance are poorly characterised and 
research must be conducted to confirm the mechanisms as well as the genetic basis for it.  
Identifying resistant strains of B. longum may allow for the development of therapeutic 
strains to be administered as prophylactics concomitantly with antibiotic therapy.  In this 
Chapter, bioinformatic analysis is presented which shows the occurrence of ABC-type 
multidrug efflux proteins in the probiotic bacterium Bifidobacterium longum subsp. longum 
JCM 1217.  Four such proteins, grouped into two gene clusters were selected for further 
investigation.  RT-PCR experiments showed that the genes are clustered into 2 operons.  
When these proteins were heterologously expressed in Lactococcus lactis, they were able to 
confer a multidrug resistance phenotype on the host cells, with a 1.5 – 3 fold increase in 
resistance to erythromycin and a 2 – 3 fold increase in resistance to tetracycline.  There was 
also an indication of the inducibility of these genes when they were exposed to erythromycin 
for prolonged periods as observed in the RT-PCR experiments.  When the heterologously 
expressed proteins were exposed to the fluorescent chemical – Hoechst 33342, a known 
substrate of ABC-type transporters, an increase in the rate of efflux of this molecule was 




Bacteria utilise transporter proteins to carry useful molecules into the cell and unwanted or 
waste molecules out of the cell.  The advent of antibiotic therapy to treat bacterial infections 















specifically directed towards these toxic molecules such as membrane alterations to reduce 
permeability, enzymes to degrade the foreign molecules and alteration of the drug binding 
site to prevent the desired mode of action.  The recruitment of transporter proteins to this end 
is thus not surprising as they allow the bacterium to rid the cell of the toxic molecule before it 
is able to carry out its toxic effect inside the cell.  Even though specific transporters exist 
which target only one molecule, one of the most important developments was the evolution 
of multidrug transporters which are able to confer resistance to numerous, structurally 
unrelated molecules at the same time, using only one or two protein molecules to pump the 
antimicrobial substance out of the cell.  This confers a great competitive advantage to the 
bacterium by increasing its pathogenicity and virulence, however, the potential for 
disseminating these genes to other would be pathogens cannot be ignored.  Even though 
numerous families of bacterial transporters have been identified, such as the major facilitator 
superfamily, the resistance-nodulation-cell division family, etc, the most intriguing are the 
ATP-binding cassette type family of transporters (ABC-type) as they are able to actively 
extrude toxic molecules with the concomitant hydrolysis of ATP.  These transporters present 
an excellent target for drug design, as specifically inhibiting the ATP binding ability of these 
transporters would render the bacterium sensitive to numerous antimicrobials and would thus 
allow for treatment with antibiotics which may have become ineffectual (Putman et al., 
2000). 
Various mechanisms are employed by bacteria to confer antibiotic resistance on the cell, but 
the multidrug efflux system is of particular interest.  This mechanism allows the bacterium to 
be simultaneously resistant to numerous structurally unrelated antimicrobial substances using 
only one or two protei s.  The primary transporters of the ATP-binding cassette (ABC) 
family are integral membrane proteins known to encode multidrug resistance proteins 
(MDR).  This family of transporters relies on the active hydrolysis of ATP to facilitate 
transport of antimicrobial substance across the cell membrane.  All ABC-type transporters 
possess the Walker domains and six transmembrane domains as a half-transporter.  Full 
ABC-type transporters function as homodimers comprising two protein polypeptides bound 
to each other.  The Walker domains comprise three conserved motifs used to bind and 
hydrolyse ATP once an antimicrobial substance has been trapped in the transmembrane 
domains.  Hydrolysis of the bound ATP facilitates the active extrusion of the antimicrobial 
substances from the cell membrane back into the surrounding medium.  The final full-















for active transport through the channel formed by twelve transmembrane segments 
(Davidson et al., 2008; Higgins, 2001). 
Cloning and functional heterologous expression of proteins requires specialised systems to 
allow for stable production of the foreign molecule.  This is even more complex when 
membrane proteins are expressed, since any changes to the bacterial membrane composition 
could destabilise it and allow for uncontrolled movement of molecules across the membrane.  
Not all MDR proteins are constitutively expressed and they often require specific inducing 
conditions or the presence of an inducer molecule to induce their transcription.  Once 
transcription is induced, it must be tightly controlled since uncontrolled expression could 
compromise the integrity of the bacterial cell membrane.  The choice of a heterologous 
expression system, therefore, must thus take into consideration all these factors to provide the 
optimal conditions for stable gene expression.  The Escherichia coli KAM3 and KAM32 
(Chen et al., 2002; Morita et al., 1998) gene expression systems allow for the heterologous 
expression of efflux transporters since these host cells have been mutated in the major E. coli 
efflux pump, acrAB, rendering it defunct.  This allows easier observation of any heterologous 
contribution by the heterologous efflux proteins.  
The Nisin Controlled Expression (NICE) system is one of the most widely used expression 
systems for the heterologous expression of Gram positive membrane proteins, especially 
those from lactic acid bacteria and allows for tight control of expression using the nisin 
inducible promoter (Mierau & Kleerebezem, 2005).  It comprises a system of two host strains 
of L. lactis: L. lactis NZ9000 and L. lactis NZ9700, which are both resistant to nisin – an 
antimicrobial peptide produced by L. lactis NZ9700.  L. lactis NZ900 has been genetically 
engineered to be deficient in nisin production, but, still remain resistant to it.  A plasmid was 
isolated from L. lactis MG1363, the wild type parental strain of NZ9000, and two expression 

















Figure 2.1.  Vector diagram of pNZ8048 used for heterologous gene expression in L. lactis. 
The vectors contain a nisin inducible promoter, which allows for transcription of exogenous 
genes when cloned in frame at the transcription start site, i.e. transcriptional fusion.  The 
vector pNZ8048 has a chloramphenicol resistance cassette to allow for antibiotic selection of 
recombinants.  There is also a small multiple cloning site, a transcription terminator and an 
origin of replication.  These vectors have been successfully used to functionally express other 
exogenous membrane proteins (Mierau & Kleerebezem, 2005).  For this reason the NICE 
system was chosen as the ideal system for functionally characterising the selected 
Bifidobacterium longum JCM 1217 ABC-type transporters in this study. 
The active extrusion of antimicrobial substances from the cell requires that the substance be 
recognised by the transporter and bound before being actively pumped out of the cell.  To 
measure this process in real time necessitates a traceable molecule which is a substrate of the 
transporter being studied.  Measuring the rate of efflux of a substrate requires that a known 
substrate of the transporter in question be labelled in such a manner as to allow for tracking 
of the molecule.  Different approaches can be used to label a substrate, but, altering the 
structure of a molecule by the addition of an adjunct label may alter its chemical properties 
significantly.  The use of naturally fluorescent molecules is thus preferred.  Ethidium bromide 
is a naturally fluorescent molecule and has previously been used for investigating efflux 
mechanisms in L. lactis (Bolhuis et al., 1996).  Ethidium bromide is, however, known to be 
carcinogenic and alternate substrates are preferable.  Hoechst 33342 is another useful 













































type transporters which only produces a signal when bound to DNA.  Efflux assays can thus 
carried out using this substrate to confirm the ATP-dependent mechanism employed by 
bacteria to confer resistance by measuring the active efflux of a substance from a cell 
mediated by an efflux transporter (Van Den Berg Van Saparoea et al., 2005). 
Since Hoechst 33342 is a lipophilic molecule, it is able to passively diffuse across bacterial 
membranes.  When de-energised bacteria are exposed to Hoechst 33342 in solution, the 
substrate passively crosses the bacterial envelope and floods into the cells, due to the osmotic 
difference.  Hoechst 33342 is essentially non-fluorescent in aqueous solutions and fluoresces 
only when bound to nucleic acids (Lalande et al., 1981).  This property leads to a measurable 
increase in fluorescence once inside bacterial cells.  When the cells are once more energised 
by the addition of a carbon source and the subsequent production of ATP, efflux pumps that 
are present which recognise this substrate will cause the Hoechst 33342 to be actively 
pumped out of the cell.  This efflux is observed as a decrease in fluorescence as the Hoechst 
33342 is pumped back into the surrounding medium, where it no longer produces a 
fluorescent signal.  The addition of ortho-vanadate, a known ATPase inhibitor, would at this 
point inhibit all cellular ATPases, including ABC-type efflux pumps.  This would result in 
either a dramatic increase in fluorescence as the Hoechst 33342 floods back into the cells, or 
a levelling off of (Lalande et al., 1981)the fluorescence level as a steady state is reached, or a 
marked decrease in the rate of efflux as non ATP-dependent pumps still pump out the 
Hoechst 33342 unaided by the ATP-dependent pumps (Bolhuis et al., 1994; Van Den Berg 
Van Saparoea et al., 2005; Venter et al., 2008). 
In this chapter the functional characterization of selected ABC-type transporters will be 






















3. Methods and Materials 
3.1. Bacterial strains and plasmids 
Bifidobacterium longum subsp. longumT JCM 1217 (NC_015067.1) was obtained from the 
NCIMB culture collection (NCIMB 702259), U.K.  B. longum JCM 1217 cultures were 
propagated in BY medium (Degnan & Macfarlane, 1993) supplemented with 1% Glucose 
(Sigma) (BYG medium), incubated at 37°C in an anaerobic chamber (Forma Scientific, 
Model 1024), in an atmosphere of 5% H2, 10% CO2 and 85% N2, for 24-48 hours.  
Lactococcus lactis NZ9000 and NZ9700 and the expression vectors pNZ8048 and pNZE8048 
were obtained from Abelardo Margolles, Spain.  L. lactis cells were propagated in 1% 
GSM17 (M17 medium (Sigma Aldrich) supplemented with 1% Glucose and Sucrose 
(Sigma)) and grown aerobically at 30°C without agitation, for 24 hours, with or without the 
addition of 5 µg/ml Chloramphenicol (Chl) for plasmid selection and recombinant screening. 
 
3.2. Genomic and plasmid DNA extractions 
B. longum subsp. longum JCM 1217 genomic DNA was isolated from cultures grown for 18 
hours in BYG medium.  Briefly, 2 – 4 ml of the cultures was centrifuged and the pellets 
treated with 200 µl of pre-lysis buffer [20 mM Tris-HCl (pH 8.0), 2 mM EDTA, 1.2 % Triton 
X-100, 20 mg/ml Lysozyme (Sigma)] before incubating at 37°C for 30 min with agitation.  
Proteinase K (Fermentas) (1 µl) was added and the reaction re-incubated at 37°C with 
agitation for 30 min. The genomic DNA was purified using the Genomic DNA purification 
kit (Fermentas) as per the manufacturer’s instructions with the addition of 0.5 µl RNaseA 
(Fermentas) to the final resuspension. 
Gene cloning and expression was carried out using the Nisin Controlled Expression System 
(NICE) (de Ruyter et al., 1998).  For cloning, pNZ8048 plasmid DNA was isolated from 18 
hr cultures of NZ9000 (pNZ8048), grown aerobically in 1 %GM17 + 5 µg/ml Chl at 30°C.  
Cells were treated using the same pre-lysis step as described for the genomic DNA extraction 
and then using the alkaline lysis method (Ish-Horowicz & Burke, 1981) with the addition of 

















3.3. B. longum erythromycin induction and total cellular RNA extraction 
Total cellular RNA was extracted from B. longum JCM 1217 cells grown using standard 
growth conditions (uninduced) as well as from cells grown in standard conditions with the 
addition of erythromycin (erythromycin induced) using the gradient plate method (Szybalski, 
1952).  For the bottom layer of the plates 10 ml of BYG agar containing 1 µg/ml 
erythromycin was used.  The top layer comprised 10 ml of BYG agar without erythromycin.  
The prepared gradient plate was reduced in the anaerobic chamber for 4 hours before spread 
plating 200 µl of an 18 hour culture of B. longum on the surface.  The plate was incubated 
anaerobically at 37°C for 3 – 5 days until a lawn of bacteria had grown.  The lawn was then 
washed off in BYG broth and the cells replated sequentially on fresh gradient plates of 3, 5 or 
7 µg/ml erythromycin.  The final culture was then washed into 70 ml reduced BYG 
containing 0.1 µg/ml erythromycin and grown anaerobically for 18 hrs at 37°C. 
For extracting total cellular RNA from B. longum cells the standard protocol for Gram 
positive lactic acid bacteria was adapted to work on these cells (Magni et al., 1995).  The 
following protocol was designed.  The 70 ml induced and uninduced 18 hr cultures were 
centrifuged at 10 000g for 15 min at 4°C.  Cell pellets were resuspended in a solution 
containing 200 µl 10 % SDS (Sigma); 2 ml water-equilibrated 1:1 phenol-chloroform 
isoamyl-alcohol (chloroform:isoamyl-alcohol 24:1 v/v + phenol (pH 5.5) equal volume); 2 ml 
of resuspension buffer (for 100 ml: 0.272 g Na-acetate (Sigma), 0.2 ml 0.5 M EDTA, pH 5.5 
with glacial acetic acid (Sigma)).  The resuspended pellets were then incubated at 70°C for 
10 min, centrifuged at 6000g for 5 min and the pellets discarded.  This procedure was 
repeated twice on the supernatant.  The remaining total cellular RNA was precipitated by the 
addition of 1:10 volume of 3 M Na-acetate (pH 5.5) and 2.5x the volume of cold, absolute 
ethanol (abs EtOH), and incubated for up to 18 hrs at - 20°C.  The tubes were then 
centrifuged for 30 min at 14 000g at 4°C.  The resulting pellets were air-dried and 
resuspended in 200 µl sterile, distilled water (dH2O).  The residual genomic DNA was 
removed by treating with DNase (Roche) as per kit instructions (1 U/µg nucleic acid, 18 hrs 
at 37°C).  The DNase was removed by resuspending the reaction mix in an equal volume of 
phenol-chloroform isoamyl-alcohol then centrifuging at 14 000g for 10 min.  The remaining 
phenol was removed by adding an equal volume of choloform isoamyl-alcohol (24:1) and 
then centrifuging at 6000g for 5 min.  The remaining pure, total cellular RNA was 
precipitated for up to 18 hrs at - 20°C as described above, followed by centrifugation at 















stored at - 80°C.  All RNA samples were checked for contaminating DNA by direct PCR 
using the Bifidobacterium sp. specific 16S rRNA gene primers (Table 2.1). 
 
3.4. cDNA conversions 
All cDNA conversions were carried out as per kit instructions using the ImProm-II Reverse 
Transcription System (A3800) (Promega) using the following conditions: 1 µg RNA, 0.5 µg 
random hexamer primers, 6 mM MgCl2, incubation at 42°C for 2 hours.  All conversions 
were carried out in duplicate and pooled after confirming the conversion by PCR analysis 
using the Bifidobacterium sp. specific 16S rRNA primers (Table 2.1).  All PCR products, 
DNA, RNA and plasmid extractions, as well as, restriction enzyme digest were checked by 
electrophoresing through a 0.8% agarose gel at 80 V with ethidium bromide (EtBr) staining 
and were visualised on a Gel Doc System (BioRad). 
Table 2.1. Oligonucleotide primers used. 
Primer name Primer sequence (5’ – 3’) Region targeted Size Source 
BLLJ_1838-7F CTGAACAAGTGCGTGAGGC 
BLLJ_1838-7 Intergenic 410 bp This study 
BLLJ_1838-7R CCAGCGTGGTGATGTCTG 
BLLJ_1837-6F GCGAAGACGAGCTGATAAGCG 
BLLJ_1837-6 Intergenic 420 bp This study 
BLLJ_1837-6R CCAAAGTCCAGGCGATGTG 
BLLJ_1496-5F GTGCACAACGCGAATTTGAAC 
BLLJ_1496-5 Intergenic 350 bp This study 
BLLJ_1496-5R AGCAGAATCACGCCGAACTTG 
BLLJ_1495-4F TACACCAACGACACCGATACG 
BLLJ_1495-4 Intergenic 413 bp This study 
BLLJ_1495-4R CAGGATGTAGAGCAGGTAGCCC 
BLLJ_0511IF GCCGACTTCGAAGGTGATG BLLJ_0511  
Internal Fragment 
469 bp This study 
BLLJ_0511IR CCTCCAACGTGATGAGCTACC 
Bif 164F CATCCGGCATTACCACCC Bifidobacterium sp. spec 
16S rRNA gene 
520 bp (Langendijk et al., 1995) 
Bif 662R CCACCGTTACACCGGGAA 
BLLJ_1837LF GGAAACACATGTTTCGCATCATG BLLJ_1837 and 
BLLJ_1836 genes 
3968 bp This study 
BLLJ_1836LR CGAGTAAAGCTTATCCGCTAATC 
BLLJ_1495LF AAGGAGGAGAACCCATGGGCGATACC 
BLLJ_1495 gene 1994 bp This study 
BLLJ_1495LR TTCTTGAAACACTAGTCGTTGCTCATCG 
* Underlined nucleotides indicate restriction site listed in the section 3.6. 
3.5. Reverse transcriptase – polymerase chain reaction 
All the oligonucleotide primers used in this experiment (Table 2.1) were designed using the 
genome sequence of B. longum NCC2705 (NC_004307) to target the gene homologues in B. 
longum JCM 1217.  The PCR reactions were carried out using the GoTaq PCR kit (Promega) 















MgCl2, 0.5 mM of each oligonucleotide primer, 0.5 U GoTaq, 2 µl cDNA as template or 100 
ng genomic DNA for the genomic DNA control, or 500 ng RNA for the RNA controls.  The 
PCR reactions were amplified using the following conditions in a GeneAmp 9700 
thermocycler (Applied biosystems): Initial denaturation (95°C for 5 min) followed by 
amplification using 30 cycles of denaturation (95°C for 30 sec); primer annealing (60°C for 
30 sec); elongation (72°C for 1 min); and a final elongation (72°C for 10 min).  All PCR 
products were electrophoresed through a 2 % agarose gel at 80 V and were visualised on a 
Gel Doc System (BioRad) using EtBr staining. 
 
3.6. Gene cloning and expression 
Escherichia coli KAM3 (Morita et al., 1998), an acrAB mutant derivative of E. coli TG1 and 
E. coli KAM32 (Chen et al., 2002) a mutant derivative of KAM3 lacking the ydhE gene, 
were propagated in Luria-Bertani broth at 37 °C with lateral shaking (Sambrook & Russell, 
2001).  Agar (Merck) was incorporated into solid media at a concentration of 1.5% (w/v) for 
plating.  pTZ57R/T (Fermentas) was used as a cloning vector and expressed in these strains. 
The putative MDR operon BLLJ_1837-1836 was PCR amplified using the High Fidelity 
PCR Enzyme Mix (Fermentas), from B. longum JCM 1217 genomic DNA using the 
oligonucleotide primers BLLJ_1837LF and BLLJ_1836LR which include PscI and HindIII 
restriction sites respectively (Table 2.1) to facilitate cloning into pNZ8048 by translational 
fusion to the nisin inducible promoter.  The following PCR conditions were used: Initial 
denaturation (95°C for 5 min), followed by amplification for 10 cycles: Denaturation (95°C 
for 30 sec); primer annealing (53°C for 30 sec); elongation (68°C for 4 min); then 
amplification for 20 cycles; Denaturation (95°C for 30 sec); primer annealing (54°C for 30 
sec); elongation (68°C for 4 min + 10sec/cycle); and a final elongation step (68°C for 10 
min).  The BLLJ_1837-6 PCR fragment was purified using the PCR cleanup kit (Biospin), 
simultaneously digested for 18 hrs at 37°C as per kit instructions with PscI and HindIII 
(Fermentas), and purified again.  The pNZ8048 vector was simultaneously digested for 18 hrs 
with NcoI and HindIII (Fermentas) and purified using the PCR cleanup kit.  The prepared 
















Competent NZ9000 cells were prepared for electroporation.  Cells were electrotransformed 
using the following conditions: 1010 cells/ml (≈ 100 µl of prepared cells); a single pulse at: 
2.5 KV (E=12.4 KV/cm), 200 , 25 F (Pulse length of 4.6 ms), in 2 mm cuvettes 
(Eurogentec), using 1 g of plasmid DNA.  Cells were immediately resuspended in 5 ml of 
pre-warmed 1% GSM17 broth containing 0.1 % nisin supernatant and incubated at 30°C for 1 
hr.  Chloramphenicol (5 g/ml) was then added and the culture incubated for another hour at 
30°C.  Cultures were then centrifuged and plated on 1% GSM17 agar including 5 g/ml 
chloramphenicol and 0.1 % nisin supernatant, and incubated at 30°C for 24 – 48 hours 
(Papagianni et al., 2007).  Functional clones were selected by first screening for the correct 
insert using colony PCR and subsequently spotting cell suspensions onto 1% GSM17 agar 
including 0.1 % nisin supernatant with various sub-lethal concentrations of erythromycin, 
tetracycline or streptomycin. 
The gene BLLJ_1495 was cloned in the same manner as described above, using the primers 
BLLJ_1495LF and BLLJ_1495LR to target the BLLJ_1495 gene in B. longum JCM 1217.  
The primers contained NcoI and SpeI restriction sites respectively (Table 2.1) to facilitate 
cloning into pNZ8048 by translational fusion to the nisin inducible promoter.  The target 
fragment was PCR amplified using Supertherm Taq (Southern BioCross) using the kit 
instructions and including 4 mM MgCl2.  The amplification reaction was carried out using the 
following conditions: Initial denaturation (95°C for 5 min), amplification using 30 cycles of: 
Denaturation (95°C for 30 sec); primer annealing (56°C for 30 sec); elongation (72°C for 1 
min 30 sec); and a final elongation step (72°C for 10 min).  The resulting 2 kb band was 
electrophoresed through a 0.8 % agarose gel, excised and purified using the Gel extraction kit 
(Biospin).  The product was ligated into the pTZ57R/T vector using the InsTAclone kit 
(Fermentas) and transformed into competent E. coli JM109 cells (Dagert & Ehrlich, 1979).  
Plasmid DNA was extracted from all resulting clones using the alkaline lysis (Ish-Horowicz 
& Burke, 1981).  The resulting clone bank was linearised by an SpeI restriction digest 
(Fermentas).  Since the BLLJ_1495 gene contains internal NcoI restriction sites, the resulting 
plasmid DNA was partially digested with NcoI and the resulting 1996 bp band was excised 
from a 0.8 % agarose gel and purified using the Gel extraction kit (Biospin).  The vector 
pNZ8048 was digested with NcoI and SpeI and purified using the PCR cleanup kit (Biospin) 
before ligating the BLLJ_1495 gene into it using T4 DNA ligase (Fermentas), for 18 hrs at 















The clones were first screened for insert by colony PCR analysis and then for function by 
spotting on antibiotic containing plates, as described above. 
To construct a single gene clone of BLLJ_1837, a deletion from the two gene construct 
previously made (BLLJ_1837-6) was carried out.  A restriction map of the two gene operon 
showed that a KspAI and HindIII digest would excise 1614 bp of the 1830 bp BLLJ_1836 
gene from the two gene construct, leaving only 200 bp of the BLLJ_1836 gene at the 5’ end.  
The double digest was carried out and the resulting fragment containing only BLLJ_1837 and 
200 bp of BLLJ_1836 was gel excised, purified, the sticky ends polished with T4 DNA 
polymerase (Fermentas) and then religated using T4 DNA ligase (Fermentas).  The pNZ8048 
containing BLLJ_1837 plasmid was electrotransformed, as previously described, into 




E-tests on the L. lactis cells expressing the heterologous genes (AB Biodisk, Solna, Sweden) 
were carried out as per the manufacturer’s instructions using the protocol outlined by 
Margolles et al., (2005) with the following changes: 0.1 % culture supernatant from the nisin 
producing strain L. lactis NZ9700 was added to induce transcription and incubated for 60 min 
at 30°C; the cultures were diluted back to OD660 ≈ 0.4 and 600 µl of each culture was added 
to 18 ml of 1% GSM17 sloppy agar before layering on top of 30 ml 1% GSM17 agar + 0.1 % 
nisin containing supernatant.  E-test strips were applied to the surface of the plates and the 
plates incubated for 48 hrs at 30°C before reading the results as per the manufacturer’s 
instructions (Margolles et al., 2005). 
 
3.8. Efflux assays 
The efflux assays were carried out by modifying the various protocols commonly used for 
efflux assays using whole L. lactis cells (Bolhuis et al., 1994; Bolhuis et al., 1995; Van Den 
Berg Van Saparoea et al., 2005).  Pre-cultures of the L. lactis cells harbouring the various 
gene constructs were grown for 18 hrs in 10 ml of 1 % GM17 + 5 µg/ml Chl, at 30°C.  These 















of   ≈  0.1.  The cultures were grown at 30°C until an OD660 of 0.6 – 0.8 was reached.  At this 
point the cultures were split into 2 X 40 ml cultures and 40 µl of nisin containing culture 
supernatant (0.1%) from the nisin producing strain L. lactis NZ9700 was added to induce 
transcription (Van Den Berg Van Saparoea et al., 2005) was added to one of each culture.  
For the control cultures, no nisin containing supernatant was added (1 nisin induced and 1 
uninduced).  Both cultures were grown for another 90 min at 30°C to allow for gene 
expression.  The cells were then harvested by centrifugation at 4000 rpm for 5 min and 
resuspending the pellets in 10 ml 50 mM Potassium-HEPES (pH 7.0) + 5mM MgSO4 
(Sigma).  To de-energise the cells, 50 µl of a 100 mM 2,4-Dinitrophenol solution (0.5 mM)  
(Sigma) was added and the cells were incubated for 30 min at 30°C.  To remove the 
dinitrophenol the cells were washed four times with 5 ml with 50mM Potassium-HEPES 
(pH7.0) + 5mM MgSO4, with centrifugation at 4000 rpm for 5 min between each step.  To 
measure the rate of efflux the washed cells were diluted to an OD660 of ≈ 0.5 in 15 ml of 
HEPES buffer and 22.48 µl of Bisbenzimide Hoechst 33342 (1 µM) (Sigma) was added to 
each culture.  Aliquots (200 µl) of each strain were added to the wells in black microtitre 
plates (Amersham).  Excitation (365 nm) and emission (457 nm) measurements were 
recorded at 2 min intervals for a total of 20 min using the UV optical kit in the Modulus 
Microplate Fluorometer 9300 (Turner BioSystems).  The cells were re-energised at this point 
by the addition of 10 µl of a 25 mM glucose solution was and measurements were recorded 
for 6 min at 2 min intervals.  Finally, 1.05 µl of 100 mM ortho-vanadate (0.5 mM final) 
(Sigma) was added to each well to inhibit all cellular ATPases and measurements were 
recorded for 20 min at 2 min intervals.  The same protocol was used for ethidium bromide as 






















4. Results and Discussion 
4.1. Bioinformatics 
The first B. longum subsp. longum genome to be sequenced and published in the public 
domain was that of Bifidobacterium longum subsp. longum NCC2705.  For the selection of 
genes of interest to be included in this study a fully sequenced genome would have been 
preferable, however, the genome sequence of Bifidobacterium longum subsp. longumT JCM 
1217, the strain used in this study, has only recently become available (Fukuda et al., 2011).  
As an alternative, a list of all the putative transporters in Bifidobacterium longum subsp. 
longum NCC2705 was consulted at http://www.membranetransport.org/.  This list (Appendix 
Figure A2.1) identifies genes which may code for transporter proteins based on conserved 
domain identity.  Since this study is focussed on ABC-type transporters, only those 
transporters in the list were considered for future work.  Of particular interest were the two 
gene clusters identified as BL0160-2-3 and BL1765-6-7 (Table 2.2).  Both of these gene 
clusters contain a putative transcriptional regulator and two adjacent genes, which are each 
classified as putative multidrug resistance genes which contain both an ATP-binding cassette 
(ABC) and a membrane domain as one polypeptide. 
Table 2.2. Open reading frames (ORF) investigated in this study. 
ORF in B. longum 
NCC2705 
Accession number in 
B. longum NCC2705 
ORF in B. longum 
JCM 1217 
Accession number  in 
B. longum JCM 1217 
BL0160 NP_695379.1 BLLJ_1838 YP_004221594.1 
BL0162 NP_695381.1 BLLJ_1837 YP_004221593.1 
BL0163 NP_695382.1 BLLJ_1836 YP_004221592.1 
BL1765 NP_696912.1 BLLJ_1496 YP_004221255.1 
BL1766 NP_696913.1 BLLJ_1495 YP_004221254.1 
BL1767 NP_696914.1 BLLJ_1494 YP_004221253.1 
 
Since MarR-type transcriptional regulators have previously been shown to regulate ABC-type 
transporters (Lubelski & Driessen, 2007; Putman et al., 2000), it is intriguing that the genome 
arrangement for both gene clusters is identical with two ABC-type transporter genes and a 
putative MarR-type transcriptional regulator upstream.  Using the BLASTP algorithm at the 
National Center for Biotechnology Information at www.ncbi.nlm.nih.gov and the newly 
published genome sequence for JCM 1217, the gene homologues for the gene clusters 















BLLJ_1838-7-6 and BLLJ_1496-5-4 respectively (Figure 2.2) (Table 2.2) and were used as 
the genes of interest in this study. 
 
Figure 2.2. Genome arrangement of the gene clusters BLLJ_1838-7-6 and BLLJ_1496-5-4, in B. longum JCM 1217, used in this study. 
To confirm whether these genes possessed the requisite domains necessary to function as 
ABC-type transporters, further bioinformatic analysis was carried out.  Each of the structural 
genes were subjected to a conserved domain search at www.ncbi.nlm.nih.gov using the CDD 
algorithm (Marchler-Bauer et al., 2009; Marchler-Bauer et al., 2011) (Appendix Figure 
A2.2).  The results of the CDD search showed that all four of the selected genes individually 
possessed all of the conserved domains needed to be functional transporters.  To determine 
the conservation of these domains a multiple protein sequence alignment of all four ABC-
type transporters was constructed using ClustalW (Thompson et al., 1994) (Figure 2.3). 
The results of the conserved domain architecture search, as well as, the multiple sequence 
alignments showed that all four of these genes individually possessed the Walker A 
(GXXXXGK(T/S)), Walker B (hhhhD) and the ABC-signature motif (LSGGQ) (Rees et al., 
2009; Walker et al., 1982).  The Walker A and B motifs allow for the binding and subsequent 
hydrolysis of ATP, and the signature motif is conserved in all ABC-type transporters.  To 
identify potential transmembrane domains (TMD), of which ABC-type transporters have 6 
each, necessary to form the channel where antimicrobial substances are bound and then 
transported out of the cell.  Hydropathy plots were, therefore, constructed using the KD-scale 
(Kyte & Doolittle, 1982) (Figure 2.4) to identify any potential transmembrane domains based 
on the hydropathy of the amino acid sequence and composition.  Possession of all these 
domains would putatively allow each gene to function as a full ABC-type transporter 
individually (Higgins, 1992).  Since most functional ABC-transporters function as dimers 















and their resulting proteins combine to form one functional transporter comprising 12 TMD’s 
and 2 ATPase domains.   
The results from these analyses showed that all four genes possessed all the necessary 
conserved domains to function independently as ABC-type transporters.  Even though these 
genes individually possessed all the domains needed to function as independent transporters 
the multiple protein sequence alignment indicated that they are all significantly different in 
their amino acid composition and are therefore not merely duplications of each other, but, are 
four different ABC-type transporters, each with the potential to function as a transporter in 
















Figure 2.3.  Multiple protein sequence alignment of BLLJ_1837, 1836, 1495, 1494 using Clustal W.  Similar amino acids are shaded green 
and identical amino acids are shaded blue.  The characteristic ABC-transporter conserved domains are indicated in red boxes.  (A) Walker A 
domain, (B) ABC signature motif, (C) Walker B domain. 



























































































Figure 2.4. Hydrophobicity plots of (A) BLLJ_1837, (B) BLLJ_1836, (C) BLLJ_1495, (D) BLLJ_1494.  Red bars above the major peaks 






















4.2. Genome arrangement 
The observed genome arrangement of both gene clusters is interesting as they both include a 
putative transcriptional regulator and two structural genes – each of which could possibly act 
independently as an efflux transporter.  This arrangement of functionally related genes being 
clustered together with a putative regulator is indicative of a possible operon-like structure.  
Reverse transcriptase – polymerase chain reaction (RT-PCR) experiments were conducted to 
investigate the possibility that these genes are transcriptionally linked as an operon 
(transcribed as a single transcript). 
For this experiment it is important that the conditions under which these genes are 
investigated be reflective of the conditions under which these genes would be transcribed in 
vivo.  Since these genes are putative multidrug resistance genes, their transcription may not 
be carried out under normal cellular growth conditions free from antimicrobial challenge.  
Previous experiments on this strain (Price et al., 2006) showed that pre-exposure of B. 
longum JCM 1217 to erythromycin lead to a significant increase in its minimum inhibitory 
concentration (MIC) of this bacterium to erythromycin on subsequent challenge.  In this 
study total, cellular RNA was, therefore, harvested from cells grown under normal cellular 
growth conditions, as well as, cells grown with prolonged exposure to erythromycin.  This 
RNA was subsequently converted to cDNA for RT-PCR analysis.  PCR primers were 
designed, for both gene clusters, to amplify the intergenic region between the putative 
regulator and the first ABC-type structural gene, as well as, the intergenic regions between 
the two structural genes (Figure 2.5).  In a previous study by Price et al., (2006), the ctr gene 
(BL1102), belonging to the family of secondary transporters, was identified and functionally 
classified as a Na+-deoxycholate transporter, which specifically transports only Na+-
deoxycholate.  The ctr gene should not respond to erythromycin challenge since 
erythromycin is not a substrate for this transporter.  To ensure that any transcriptional 
changes which may occur as a result of erythromycin challenge are specific in response to 
this erythromycin exposure, the gene homologue of BL1102 in B. longum JCM 1217 
(BLLJ_0511) was included as a comparative control in this experiment.  The RT-PCR was 
conducted using the following nucleic acid targets: genomic DNA extracted from JCM 1217, 
as well as, the cDNA produced from the uninduced and the erythromycin induced total RNA 

















Figure 2.5. Position of primers designed to amplify the intergenic regions between the genes of interest, as well as, the internal fragment 
region of the control ctr gene.  The black and purple arrows indicate the two intergenic regions targeted and the red arrows indicate the 
internal fragment of the ctr gene. 
 
Figure 2.6. RT-PCR of the intergenic regions BLLJ_1838-7 and BLLJ_1837-6 and the ctr gene fragment.  Lanes 1, 4, 7, genomic DNA 
target; lanes 2, 5, 8, uninduced cDNA target; lanes 3, 6, 9, erythromycin induced cDNA target; lane 10, no template control. 
Since no amplicon was generated from the BLLJ_1838-7 intergenic PCR, the results obtained 
clearly indicated that that the gene cluster BLLJ_1838-7-6 is transcribed as a two gene 
operon comprising the two structural genes BLLJ_1837-6, excluding the putative 
transcriptional regulator BLLJ_1838.  The BLLJ_1838-7 intergenic PCR was repeated with 
double the amount of cDNA to ensure there was no error due to primer specificity, but, even 
using these highly favourable conditions, no amplicons were observed.  The operon was 
constitutively transcribed under both normal growth conditions and erythromycin induced 
conditions.  Equal molar concentrations of RNA were converted to cDNA for both the 
uninduced and the erythromycin induced conditions in duplicate, and equal volumes of 
cDNA were used for the RT-PCR, as well as, equal loading of PCR products on gels.  
Therefore there appeared to be a slight semi-quantitative increase in transcription levels of 















as a visible increase in band intensity when compared to the uninduced condition (Figure 2.6, 
lane 8).  These results were reinforced by the unchanged transcription levels of the ctr gene, 
even in the erythromycin induced condition (Figure 2.6, lanes 2 and 3).  To ensure these 
results were accurate, control experiments were conducted to ensure the extracted RNA was 
free of residual DNA.  These experiments showed no presence of DNA even when 500 ng of 
RNA was used as template (data not shown).  Internal fragment primers were also designed 
to ensure all the genes being studied were represented in the cDNA produced from the 
extracted RNA.  These experiments showed that all the genes were present in sufficient 
concentrations to be detectable (data not shown). 
For the second gene cluster (BLLJ_1496-5-4) the same procedure as described above was 
followed.  Figure 2.7 shows the primer positions of the intergenic regions and Figure 2.8, the 
RT-PCR results of this region. 
 
Figure 2.7. Position of primers designed to amplify the intergenic regions for BLLJ_1496-5-4.  The black and purple arrows indicate the two 
intergenic regions targeted. 
 
Figure 2.8. RT-PCR of the intergenic regions between BLLJ_1496-5 and BLLJ_1495-4.  Lanes 1 and 4, genomic DNA target; lanes 2 and 5, 
uninduced cDNA target; lanes 3 and 6, erythromycin induced cDNA target; lane 7, no template control. 
Since amplicons are produced from both intergenic region PCR reactions, the results 















comprising the two ABC-type structural genes BLLJ_1495-4 and including the putative 
transcriptional regulator BLLJ_1496.  The operon was transcribed under both normal growth 
conditions and erythromycin induced growth conditions.  As was observed in the first RT-
PCR results, there appeared to be a slight semi-quantitative increase in transcription levels of 
this operon under erythromycin induced conditions (Figure 2.8 lanes 3 and 6), which could be 
seen as a visible in increase in band intensity compared to the uninduced condition (Figure 
2.8 lanes 2 and 5).  
 
4.3. Cloning of putative MDR genes and functional heterologous expression 
Heterologous expression of membrane proteins is not easily accomplished and requires 
systems that can accommodate the added load on the host cell, as well as the necessary 
cellular machinery to functionally express the heterologous proteins and stably integrate them 
into the membrane.  Initial attempts at cloning and functionally expressing these genes in 
systems such as E. coli KAM3 and KAM32 (Chen et al., 2002; Morita et al., 1998) were 
undertaken but were unsuccessful, even though numerous strategies were employed to 
improve stability and expression.  This was possibly due to the heterologous expression of 
Gram positive membrane proteins in a Gram negative host.  To increase the probability of 
obtaining a functional clone a Gram positive expression system was chosen.   
Cloning the BLLJ_1837-1836 two gene operon into pNZ8048 was accomplished using 
translational fusion, by exploiting the ATG codon in the NcoI restriction enzyme site in the 
pNZ8048 vector (Figure 2.1).  Since the BLLJ_1837-1836 gene sequence contains an internal 
NcoI restriction site, the forward primer used for PCR amplifying the gene from the B. 
longum JCM 1217 genomic DNA was designed to include a PscI restriction site, at the ATG 
start codon of the BLLJ_1837 gene, which produces complementary ends for cloning into a 
NcoI site.  A HindIII restriction site was included in the reverse primer to facilitate 
directional cloning into the vector.  Positive recombinant clones were screened for function 
by plating serial dilutions of these cultures on 1 % GM17 + 0.1 % nisin plates with varying 
sub-lethal concentrations of antibiotics, and the clone with the highest increase in resistance 
compared to the control (NZ9000 + pNZ8048) was selected for further work.  This clone 
(Clone 23) (NZ9000 + pNZ8048:1837-6) was checked for the correct insert with restriction 
















(a)                (b)  
Figure 2.9. Functional clone selection and insert confirmation with restriction digests. (a) Example of plate spotting a serial dilution of 
bacteria (100 – 10-8) showing increased MIC levels of the selected Clone 23 (blue arrow) compared to the control (C) plated on 1 % GM17 + 
0.1 % nisin with 40 µg/ml streptomycin (Str 40). (b) Restriction digests of the selected Clone 23; M, λ DNA – PstI digest molecular weight 
marker, lane 1, XhoI digest; lane 2, SalI digest; lane 3, undigested pNZ8048 + BLLJ_1837-6 Clone 23 plasmid DNA. 
 
Table 2.2. List of recombinant gene constructs for heterologous expression in L. lactis. 
Name of construct B. longum JCM 1217 ORF being expressed 
pNZ8048 None (vector without insert) 
pNZ1837-6 BLLJ_1837 and BLLJ_1836 
pNZ1837∆6 BLLJ_1837 and (200bp 5’ BLLJ1836) 
pNZ1495 BLLJ_1495 
 
To determine the individual contribution of each gene of the cluster BLLJ_1837-6 to the 
observed increase in MIC to antibiotics, a deletion of the BLLJ_1836 gene from the two gene 
construct already produced was carried out (Figure 2.10).  Restriction enzyme digestion was 
used to excise all but 200 bp of BLLJ_1836 at the 5’ end of the gene.  This would produce a 
clone which is non-functional in BLLJ_1836 expression since it would lack 5 of the TMD’s, 
as well as, both of the ATP-binding domains.  Any MDR function observed from this 























(a)                         (b)  
Figure 2.10. Agarose gels showing the construction of pNZ8048+BLLJ_1837∆6. (a) Plasmid DNA showing the restriction digestion of 
BLLJ_1836. M, λ DNA – PstI digest molecular weight marker; lane 1, pNZ8048+BLLJ_1837-6 super-coiled plasmid DNA; lane 2, 
pNZ8048+BLLJ_1837-6 digested with KspAI to linearise (7.25 kb); lane 3, pNZ8048+BLLJ_1837-6 digested with HindIII and KspAI to 
excise the ≈ 1.5 kb fragment of BLLJ_1836 DNA. (b) Plasmid extraction from positive clones of BLLJ_1837. M, λ DNA – PstI digest 
molecular weight marker; lane 1, pNZ8048+BLLJ_1837-6 XhoI digest (linearised); lane 2, positive clone of pNZ8048+BLLJ_1837∆6 (≈ 
1.5 kb smaller). 
From the above result, it can be seen that the BLLJ_1836 gene product was successfully 
deleted from the two gene construct and a stable, positive clone (NZ9000 + pNZ1837∆6) was 
isolated. 
Attempts to clone the two gene operon comprising BLLJ_1495-4 were conducted using a 
similar approach as above.  Recombinant clones were obtained and were confirmed by 
colony PCR.  The clones were sub-cultured but all exogenous DNA was subsequently lost 
from the clones.  Repeated attempts at improving the clone stability, such as plating on 
antibiotics had no effect on increasing the insert stability.  In an attempt to produce a stable 
clone of these genes, only one of the genes in the operon (BLLJ_1495) was cloned and 
expressed in this system.  A stable, functional clone (NZ9000 + pZN1495) was isolated and 
the insert confirmed with colony PCR, restriction digests and DNA sequencing analysis as for 
all the other gene constructs.  All of the gene constructs produced were subsequently 























4.4. Functional expression of ABC-type transporters and multidrug resistance 
To conclusively prove that the recombinant constructs produced in this study did in fact 
confer multidrug resistance (MDR) on the host, the ABC-type transporter genes were tested 
to ascertain if they conferred increased resistance to various structurally unrelated 
antimicrobial substances in vivo.  To test this hypothesis, the constructs described above were 
all subjected to minimum inhibitory concentration analysis using the E-test method (Figure 
2.11) (Margolles et al., 2005).  The antibiotics selected for this were erythromycin 
(macrolide), tetracycline (polyketide) and streptomycin (aminoglycoside) as they have 
previously been shown to be substrates of ABC-type transporters (Margolles et al., 2005).  
An increase in MIC in response to two or more of these antibiotics would indicate an MDR 
phenotype. 
(a)   (b)  
Figure 2.11. E-test MIC determinations of L. lactis cells harbouring the various gene constructs in this study compared to the host 
harbouring the vector without insert (pNZ8048).  The Fold increase of all clones in response to (a) erythromycin challenge and (b) 
tetracycline challenge is plotted.  Numbers above each bar indicate the MIC in µg/ml. 
These results (Figure 2.11) conclusively show a MDR phenotype, as all of the constructs 
increase the resistance of the host cell to both erythromycin and tetracycline by 1.5 – 3 folds.  
It is interesting that the two gene construct BLLJ_1837-6 produces the same MIC as the 
single gene construct BLLJ_1495 in response to erythromycin challenge.  The single gene 
construct BLLJ_1837∆6, in response to erythromycin, produced an MIC which is exactly half 
that of the two gene parent construct, indicating that the phenotype produced is as a result of 
the equal contribution of both genes to the increased MIC.  In response to tetracycline, the 



























































the same level of resistance as was observed in response to erythromycin challenge.  This 
indicated the poly-specific nature of MDR transporters for their substrates (Aller et al., 2009; 
Davidson et al., 2008).  Even though MDR transporters have diverse substrate profiles the 
specificity of each transporter binding each substrate will determine the level of efflux, as 
well as, which transporters are recruited in response to antimicrobial challenge.  In response 
to tetracycline, the single gene construct, BLLJ_1837∆6, had an MIC which was lower by 
one fold compared to that of the two gene parent construct, BLLJ_1837-6.  This showed that 
the phenotype results from a dual effect produced unequally by the contribution of both genes 
in this cluster.  No increase in MIC was observed in response to challenge with streptomycin 
(results not shown), indicating it is not a substrate for any of these proteins. 
 
4.5. Active efflux 
Efflux assays were designed and carried out on all the constructs produced in this study to 
ascertain whether the rate of active ATP-dependent efflux was increased in the presence of 
the heterologous B. longum putative ABC-type efflux proteins when expressed in L. lactis.  
The presence of the nisin inducible promoter allowed for the direct comparison of the cells 
harbouring the pNZ8048 vector with the respective ABC-type transporter genes in the 
induced and uninduced states (Figure 2.12).   
No visual increase in the levels of efflux can be directly observed from the results obtained.  
The primary reason for this is the high background of ATP-dependent efflux activity in the L. 
lactis expression system, which is known to possess highly efficient efflux systems (Bolhuis 
et al., 1996; Margolles et al., 1999; Zaidi et al., 2008).  In this background, it becomes 
difficult to note the contribution of the exogenous B. longum ABC-type transporters to the 
basal rate of efflux, even though it has previously been proven that they are functional and 
confer a MDR phenotype on these cells.   
A notable decrease in the maximum accumulation of Hoechst 33342, by approximately 200 
units observed at 480 seconds, can be seen in cells harbouring the exogenous ABC-type 
transporters BLLJ_1837-6 and BLLJ_1387∆6, in the nisin induced condition.  This may be 
due to some residual efflux of Hoechst 33342 during the uptake phase of the assay the ABC 
transporters themselves, which may still have some bound ATP.  Alternatively, it may be due 















membrane structure and may structurally impede the influx of Hoechst 33342 in to cells to 
some extent which may differ from the host cells not expressing these exogenous genes. 
(a)  
(b)  
Figure 2.12. Hoechst 33342 efflux from whole L. lactis NZ9000 cells harbouring the ABC-type constructs. (a) Cells not induced by nisin; 
(b) cells induced with nisin.  Fluorescence values are represented in arbitrary units (AU).  Blue arrows indicate the addition of glucose.  Red 







































































Another interesting observation was that even though the cells were de-energised before the 
addition of the Hoechst 33342, there was a steady decrease in the fluorescence levels for all 
the constructs from the outset of the experiment.  This may have been due to some residual 
efflux of the substrate by transporters which may still have had some energy reserves 
available or by transporters which were not solely reliant on ATP for their activity.  This 
highlighted the high levels of constitutive background efflux present in this system.  The 
subsequent addition of ortho-vanadate, a known ATPase inhibitor, lead to a decrease in the 
overall rate of efflux and the establishment of an eventual steady state by all the ATP-
dependent transporters both endogenous and exogenous, in L. lactis.   
To mathematically determine the empirical rates of efflux, the slope of each graph was 
calculated during the energised efflux phase between T = 1452 and T = 1584 (Table 2.3).  
The rates of active efflux during the glucose re-energising phase showed a notable increase in 
efflux for cells harbouring the exogenous ABC-type transporters. 
Table 2.3.  Rates of active efflux from L. lactis harbouring ABC-type constructs in nisin uninduced (w/o) and 
nisin induced (w) conditions. 
Construct Slope % Difference 
pNZ8048 w/o -0.1508 - 1.003 pNZ8048 w -0.1609 
pNZ1837-6 w/o -0.1077 - 16.387 pNZ1837-6 w -0.2716 
pNZ1837∆6 w/o -0.1154 - 7.134 pNZ1837∆6 w -0.1867 
pNZ1495 w/o -0.1227 - 2.843 pNZ1495 w -0.1512 
 
From these calculated values it became evident that expression of the exogenous ABC-type 
transporters made a contribution to the rate of efflux when the L. lactis host cells were re-
energised by the addition of glucose.  The difference in the rates of efflux between nisin 
uninduced and nisin induced cells harbouring the pNZ8048 vector without any insert was an 
increase of 1 %.  This indicated that the empty vector’s contribution to efflux was negligible 
even when the host cells were grown in nisin inducing conditions.  This was not the case for 
the cells harbouring the ABC-type transporters BLLJ_1837-6 (pNZ1837-6) and 
BLLJ_1837∆6 (pNZ1837∆6).  Expression of the two gene operon BLLJ_1837-6 lead to a 
16.4 % increase in the rate of active efflux from the host cells in the nisin induced condition 
when compared to its uninduced counterpart.  The single gene construct BLLJ_1837∆6 
















The same trend was observed for BLLJ_1495 (pNZ1495) expression in the nisin induced 
condition, where a 2.8 % increase in efflux was observed compared to the uninduced culture.  
Even though the increase in the rate of efflux was much lower than that of either of the two 
previously described constructs, it was still higher than the background seen with the empty 
vector, and therefore shows that this protein is an ABC-type transporter, which actively 
exports Hoechst 33342 by the hydrolysis of ATP. 
Similar results were obtained when this experiment was repeated with ethidium bromide, 
another fluorescent molecule known to be a substrate of ABC-type transporters (Bolhuis et 
al., 1994; Bolhuis et al., 1995).  Using this substrate, no significant increase in the levels of 
efflux could be observed due to background efflux activity of the L. lactis cells (results not 
shown).  In other studies characterising Hoechst 33342 and ethidium bromide efflux, using L. 
lactis cells, much stronger evidence of active extrusion was observed.  This was due to the 
fact that the genes being studied (lmrA and lmrP) were in fact genes which occurred in the 
host L. lactis cells.  This expression system allowed for over-expression of genes already 
present (Margolles et al., 1999) and also for the construction of knock-out mutants, lacking 
the genes being characterised, which then allowed for the characterisation of the gene of 
interest when the mutant host cell was complemented with the gene being expressed on a 
plasmid (Bolhuis et al., 1995). 
The results obtained here indicated that the heterologously expressed genes may in fact be 
ATP binding cassette type transporters, as indicated by the complete inhibition of ATP-
dependent efflux when the ATPase inhibitor ortho-vanadate was added.  There was also an 
indication that the cells expressing the heterologous B. longum ABC-type proteins appeared 
to actively extrude Hoechst 33342 by the hydrolysis of ATP, although, that a better 






















This chapter confirms the presence of two putative multidrug efflux systems in B. longum 
JCM 1217.  The two MDR systems are transcribed as operons, one composed of two ABC-
type efflux genes with a separate putative transcriptional regulator, and the other comprising 
two ABC-type efflux genes inclusive of a putative transcriptional regulator.  The ABC-type 
efflux genes were shown to confer an MDR phenotype when expressed in L. lactis and 
contribute to the increase in resistance to both erythromycin and tetracycline.  The rate of 
efflux of a fluorescent substrate, Hoechst 33342, appeared to be increased when these genes 
were heterologously expressed in L. lactis.  Unfortunately, due to the high background efflux 
in the L. lactis NICE system this could not be proven conclusively and should in the future be 
carried out in a system where the major efflux systems have been mutated to be 
dysfunctional, or where deletions of the actual gene homologues being studied can be carried 
out.  These results strongly indicate that the genes BLLJ_1837, 1836 and 1495 are ABC-type 
MDR genes, which appear to actively extrude antimicrobial substances by the hydrolysis of 
ATP.   
From the results obtained in the RT-PCR, the genes also appeared to be transcriptionally 
upregulated when the host was exposed to erythromycin, a known substrate of these types of 
efflux genes.  These results were merely qualitative and the inducibility of these genes merits 
further investigation.  This will be covered in Chapter 3 of the study.  The presence of two 
putative transcriptional regulators in these gene clusters is also intriguing and their roles will 
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The advent and administration of antibiotic treatment has allowed for a significant decrease 
in the morbidity due to bacterial infections.  Unfortunately, the irresponsible use of 
antibiotics and the rapid evolutionary adaptations by bacteria to these drugs has lead to a 
situation where multidrug resistance is a common and ever increasing problem which 
necessitates the constant development of new drugs to treat ‘old bacteria’.  This Chapter 
presents experimental data showing the inducibility of antibiotic resistance in B. longum JCM 
1217 when pre-exposed to erythromycin.  The results showed a dramatic increase (> 200 
fold) in the MIC to erythromycin.  Using quantitative Real Time PCR, the transcriptional 
profiles of the ABC-type multidrug efflux genes identified and characterised in Chapter 2, are 
also presented.  This data indicated that these genes are transcriptionally up-regulated in 
response to erythromycin exposure, by ≈ 1.5 – 3 folds, and may therefore play a role in 
conferring resistance to this antibiotic. 
 
2. Introduction 
In Chapter 2 of this study, ABC-type transporter genes were identified in the genome of B. 
longum JCM 1217.  Using various experimental techniques they were proven to be 
transcriptionally linked and conferred a multidrug resistance phenotype on the host when 
heterologously expressed in L. lactis cells.  There was an indication that they were able to 
actively extrude Hoechst 33342, a fluorescent substrate of known ABC-type transporters, and 
this was done in a manner which appeared to be dependent on ATP hydrolysis.  An 
interesting finding was the indication of an increase in the gene transcription levels of these 
ABC-type transporters genes when the cells were grown with prolonged exposure to 
erythromycin, corresponding to a concomitant increase in the erythromycin MIC.  Since these 
ABC-type transporter genes directly confer resistance to erythromycin when heterologously 
expressed, the upregulation of their transcription in response to erythromycin is not 
surprising.  It is, however, important to show that this upregulation is not a general cellular 
stress response, but rather a response by specific antibiotic resistance genes to erythromycin 
exposure. 
The data presented thus far merely gave a qualitative indication of gene upregulation.  It is, 















method which can accurately determine any changes in the gene transcription levels in 
response to this erythromycin exposure.  The advent of quantitative real-time PCR (qRT-
PCR) indicated a milestone in molecular science, since this method allowed for the indirect 
determination of the levels of gene transcription based on their respective mRNA levels, in 
real time.  This was accomplished by harvesting the total cellular RNA, converting it to 
cDNA, and using this cDNA as a template for PCR to measure the amount of starting 
material, with the aid of a standard curve of known concentrations, based on the increase in 
fluorescence as more ethidium bromide bound to the double stranded DNA being formed 
(Higuchi et al., 1993).  Since then, a number of advances in this science have refined it, 
allowing it to be used to accurately and reliably quantify unknown DNA concentrations.  The 
development of TaqMan based qRT-PCR made it even more sensitive than the commonly 
used SYBR green technology and even more reliable since primer-dimers produce no signal, 
a common artefact of SYBR green based qRT-PCR.  TaqMan based qRT-PCR relies on the 
5’ exonuclease activity of Taq polymerase to hydrolyse a DNA bound oligonucleotide probe, 
thus releasing the attached fluorophore and producing a signal (Holland et al., 1991). 
This Chapter describes experiments conducted to determine the impact of exposure to 
erythromycin on the transcriptional levels of the B. longum subsp. longumT JCM 1217 ABC-
type transporters being investigated. 
 
3. Methods and Materials 
3.1. Gradient plate inductions 
Induction of B. longum subsp. longum JCM 1217 by erythromycin exposure was carried out 
using the gradient plate method as described in Chapter 2.  The erythromycin MIC of the 
cells was determined before exposure (basal level) and after each passage on a higher 
concentration of erythromycin, using the E-test method.  The E-tests were carried out as per 
the manufacturer’s instructions by plating a 1 McFarland (McFarland, 1907) cell suspension 
on the surface of a reduced, BYG agar plate before applying the E-test strip and then 

















3.2. RNA hybridization analysis 
To investigate the genetic response of B. longum JCM 1217 in response to erythromycin 
exposure, RNA hybridization experiments were conducted.  B. longum cells were exposed to 
erythromycin using the gradient plate method (3.1) and total cellular RNA was extracted 
from cells grown in erythromycin induced and uninduced conditions, as is described in 
Chapter 2. 
DIG-labelled, DNA oligonucleotide probes were used to determine semi-quantitatively 
whether a change in the transcription levels of each gene in this study had occurred under 
erythromycin induced growth conditions.  The DNA oligonucleotide probes were constructed 
by PCR amplification of a 1 kb fragment of DNA from the middle region of each gene being 
investigated, using the PCR primers listed in Table 3.1.  The B. longum JCM 1217 16S rRNA 
gene was used as a reference.  These DNA fragments were purified using the PCR cleanup 
kit (BioSpin) and subsequently DIG-labelled using the DIG-PCR labelling kit (Roche) as per 
the manufacturer’s instructions. 
RNA hybridization experiments were carried out by spotting 8 µg of total cellular RNA from 
erythromycin induced and uninduced B. longum JCM 1217 cells onto a nitrocellulose 
membrane (Amersham).  The RNA was then UV crosslinked and probed individually with 
each individual DNA oligonucleotide probe constructed using the primer sets in Table 3.1.  
The membranes were then visualised as described in the DIG-manual (Roche). 
Table 3.1. List of oligonucleotide primers used for RNA hybridization experiments. 
Primer name Primer sequence (5’ – 3’) Region targeted Size Source 
BLLJ_1837PF CATCGTCGGGCAGGTCTACTTC 
BLLJ_1837 Internal Fragment 1 Kb This study 
BLLJ_1837PR GCGAATCCGGGTAGGTGAAG 
BLLJ_1836PF CGTGAACTACTGCCGCAACTATC 
BLLJ_1836 Internal Fragment 1 Kb This study 
BLLJ_1836PR CAAAGCGGACTTGTCGGATTCG 
BLLJ_0511PF GCCTTTGCAGATTGGCTGA 
BLLJ_0511 Internal Fragment 1 Kb This study 
BLLJ_0511PR CCGCTGAAACGGTGCTCTT 
BLLJ_1495PF TGGTGGTCGTATCCTGGC 
BLLJ_1495 Internal Fragment 1 Kb This study 
BLLJ_1495PR TACCGCCCTGCTCGATG 
BLLJ_1494PF GCTCTACATCCTGCTTGCC 
BLLJ_1494 Internal Fragment 1 Kb This study 
BLLJ_1494PR CCAGCTTGCACAACCTCTTC 
Lm26F GATTCTGGCTCAGGATGAACG 
B. longum specific 16S rRNA 1.35 Kb (Kaufmann et al., 1997) 
Lm3R CGGGTGCTICCCACTTTCATG 
Bif164F CATCCGGCATTACCACCC Bifidobacterium specific 
16S rRNA gene 
520 bp (Langendijk et al., 1995) 
Bif662R CCACCGTTACACCGGGAA 















3.3. Determination of sub-lethal erythromycin inducing conditions 
B. longum JCM 1217 cells grown in BYG broth were exposed to various concentrations of 
erythromycin to determine the sub-lethal concentration of erythromycin and the effect on 
their growth rate was monitored.  B. longum JCM 1217 cells were grown for 18 hours in 10 
ml of reduced BYG broth as described in Chapter 2.  This culture was re-inoculated into 100 
ml of reduced BYG broth and grown anaerobically until an OD600nm ≈ 0.3, corresponding to 
mid-log growth phase, was reached.  At this point, varying concentrations of erythromycin 
(0.0/ 0.5/ 1.0/ 2.0/ 4.0 µg/ml) were added to each culture and the incubation continued with 
the optical density measured every hour for a total of 28 hours. 
3.4. Quantitative Real Time – PCR (qRT-PCR) 
Changes in the transcription levels of the selected genes, after erythromycin exposure, were 
quantified using quantitative Real Time PCR (qRT-PCR).  B. longum JCM 1217 cells were 
induced by growing them as described in 3.3, with the addition of 0.0, 1.0 or 2.0 µg/ml 
erythromycin at mid-log phase (OD600nm ≈ 0.3).  After 2 hours of growth under these 
conditions, total cellular RNA was extracted from all of the cultures using the method 
described in Chapter 2 with the addition of a final purification step using the RNeasy kit 
(Roche) as per the manufacturer’s instructions.  All experiments were conducted in triplicate. 
cDNA conversions were carried out using the Bioline cDNA conversion kit as per the 
manufacturer’s instructions using 2 µg of RNA per 20 µl reaction.  The random hexamer 
primers were annealed to the RNA at 65°C for 10 min before incubating the reactions at 42°C 
for 18 hours to allow for complete cDNA synthesis of all cellular RNA.  The reactions were 
heat inactivated at 70°C for 15 min.  To reduce experimental error during the cDNA 
conversions, all the reactions were carried out in duplicate and checked for the production of 
cDNA, using the Bifidobacterium sp. specific primers Bif164F and Bif662R (Table 3.1), 
before pooling the duplicate reactions. 
To accurately determine the change in the gene expression levels during erythromycin 
exposure, qRT-PCR analysis was conducted using the oligonucleotide primers in Table 3.2 
and the oligonucleotide probes in Table 3.3.  All the primers and probes used were designed 
using the Beacon Designer 7.21 software (PREMIER Biosoft International) to be compatible 
for a multiplex PCR.  The resulting primer/probe sets with the highest compatibility were 















fragment of BLLJ_1495 and BLLJ_1837 using the Taqman method of qRT-PCR.  All the 
reactions were setup as multiplex PCR reactions which included the 16S rRNA primers and 
probe, as well as, the gene of interest (GOI) primers and probe.  Since the BLLJ_0511 ctr 
gene showed no discernible change in transcription when exposed to erythromycin (Chapter 
2) it was also included as a comparative gene of interest to determine if any cross-induction 
could be observed using a more sensitive technique. 
A typical SYBR green qRT-PCR reaction was as follows.  For a 50 µl reaction using the 2 X 
SensiMix dT Kit (Quantace): 200 nM of each primer, 1 X SensiMix, 1 µl SYBRO, 100 ng B. 
longum genomic DNA as template for optimization.  All reactions were conducted on the 
Rotor-Gene 6000 Series (Corbett Life Science) using the software version 1.7.87.  The 
following cycling conditions were used: Initial activation at 95°C for 10 min; 40 cycles of 
denaturation at 95°C for 10 sec, primer annealing at 60°C for 15 sec, and elongation at 72°C 
for 15 sec.  A DNA melt curve was added at the end of this by ramping the temperature from 
67°C – 95°C at 1°C/cycle. 
Table 3.2. List of oligonucleotide primers used for qRT-PCR experiments. 
Primer name Primer sequence (5’ – 3’) Region targeted Size Source 
16S1495F AGTGAGTTTACCCGTTGAATAAGC 
16S rRNA gene 150 bp This study 
16S1495R CACCGTTAAGCGATGGACTTTC 
Q1495F CCATGTCACCTTCCGCTACTC 
BLLJ_1495 Internal Fragment 137 bp This study 
Q1495R GCACGAGCTGTACCAGAGAC 
16S1837F AGTGAGTTTACCCGTTGAATAAGC 
16S rRNA gene 150 bp This study 
16S1837R CACCGTTAAGCGATGGACTTTC 
Q1837F GAGGCCAAGGATTCCACCAAG 
BLLJ_1837 Internal Fragment 134 bp This study 
Q1837R TCGCAGTTGTCGAGCAGTTC 
16S0511F AAGAACCTTACCTGGGCTTGAC 
16S rRNA gene 127 bp This study 
16S0511R TGCGGGACTTAACCCAACATC 
Q0511F AGATCATGTGGCAGATCACACC 
BLLJ_0511 Internal Fragment 103 bp This study 
Q0511R CTCGCTTCTCAGTACGTGTCC 
 
Table 3.3. List of oligonucleotide probes used for qRT-PCR experiments. 
Probe name Primer sequence (5’ – 3’) Region targeted Size Source 
P16S1495 CGACGAACCGCCTACGAGCCCTTT 16S rRNA Internal Probe 24 bp This study 
P1495 AACCAGTACCGCCGACGATGCCG BLLJ_1495 Internal Probe 23 bp This study 
P16S1837 CGACGAACCGCCTACGAGCCCTTT 16S rRNA Internal Probe 24 bp This study 
P1837 TGCCCTGACCCACGACCTTGCC BLLJ_1837 Internal Probe 22 bp This study 
P16S0511 CGAGCTGACGACGACCATGCACCA 16S rRNA Internal Probe 24 bp This study 
P0511 CGGGAAGAGCACCACCTTGACGGC BLLJ_0511 Internal Probe 24 bp This study 
 All 16s rRNA internal probes were 5’ labelled with HEX (6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein) 
 All GOI internal probes were 5’ labelled with FAM (6-carboxyfluorescein) 















A typical TaqMan multiplex qRT-PCR reaction was as follows.  For a 12.5 µl reaction using 
the 2 X SensiMix Probe Kit (Quantace): 1 X SensiMix, 200 nM of each oligonucleotide 
primer (16S rRNA and GOI), 66.67 nM of each fluorescently labelled TaqMan probe (16S 
rRNA and GOI), as template, 25 ng B. longum genomic DNA for optimization or 1 µl of 
uninduced or erythromycin induced cDNA (diluted 1:10 in sterile dH2O) for quantitation.  
For no template controls (NTC) 1 µl sterile dH2O was used instead of DNA template and for 
RNA controls 20 ng of the extracted total cellular RNA was used as template to ensure no 
false positives were obtained as a result of residual genomic DNA in the sample.  The 
following cycling conditions were used: Initial activation at 95°C for 10 min; 40 cycles of 
denaturation at 95°C for 10 sec, coupled primer annealing and elongation at 60°C for 25 sec, 
acquiring to the green and yellow channels after each cycle.  For standard curve construction, 
equal volumes of uninduced and induced cDNA were pooled and then serially diluted from 
100 – 10-4 in sterile dH2O.  All measurements were conducted in triplicate and each replicate 
experiment was measured in the same run using the Rotor-Gene 6000 Series (Corbett Life 
Science) using the software version 1.7.87. 
 
4. Results and Discussion 
4.1. Erythromycin gradient plate inductions 
The gradient plate method was used to study the effect of erythromycin on the MIC of B. 
longum JCM 1217 cells.  This method allows for long term exposure of the cells to the 
antibiotic with the result that the bacteria have time to adjust to and stabilize in the presence 
of the antibiotic.  The drawback of this technique is that over time the bacteria may change 
the mechanisms employed to deal with the antimicrobial challenge and may lead to the 
development of persister cells or mutants (Bigger, 1944).  Figure 3.1 shows the fold increase 

















Figure 3.1. Trend graph showing the fold increase in MIC of B. longum exposed to erythromycin.  The numbers above each bar indicate the 
actual MIC in µg/ml.  Error bars indicate the standard error of the mean of 3 experiments. 
The results showed a significant increase in the MIC of B. longum JCM 1217 to erythromycin 
(≈ 240 fold) after four passages of erythromycin exposure.  Even though the results obtained 
gave a strong indication that these bacteria possessed mechanisms which allowed them to 
survive antibiotic exposure, the large error observed indicated that long term exposure may 
result in the bacterium changing the mechanisms which are recruited in response to 
antimicrobial challenge and also the extent to which they are used.  The development of 
persister cells which may become transiently resistant to the antibiotic due to the long term 
exposure is also possible (Gefen & Balaban, 2009; Keren et al., 2004).   
The persister cells which remain after the initial erythromycin exposure have been reported 
not to become resistant to erythromycin, but rather to tolerate it, and thus survive to form a 
new population of bacteria in subsequent passages of this culture onto higher concentrations 
(Gefen & Balaban, 2009).  The development of a slow growing persister population of 
bacteria would allow the culture to survive this long term antibiotic exposure and may allow 
for the changing of resistance mechanisms and the levels at which they are employed.  In this 
way the bacterium is able to still survive the antimicrobial challenge, but, may not produce 
the same MIC each time as the levels of tolerance developed may change with each 
subsequent experiment. 
This result indicated a cellular response by the bacteria to erythromycin exposure, but did not 
indicate whether the ABC-type transporter genes being studied here were in fact recruited in 


































response to these erythromycin inducing conditions.  In order to investigate whether this 
increase in MIC is in part due to the action of the ABC-type transporter genes being studied, 
the actual transcriptional changes of the ABC-type transporters need to be measured and 
compared to the uninduced condition. 
4.2. RNA hybridization analysis 
In Chapter 2 of this study RT-PCR experiments revealed a semi-quantitative increase in gene 
transcription levels of the ABC-type transporters genes being investigated, in B. longum cells 
exposed to erythromycin.  This result merely presented an indication of upregulation of the 
genes as clusters, since the region targeted by the RT-PCR was the intergenic region 
spanning the genes in the operon.  In order to determine whether the observed induction 
occurs for each gene being studied, RNA hybridization by means of dot blot analysis was 
employed.  This technique gives a qualitative indication of the gene expression levels when 
compared to a gene which remains stably expressed under the same conditions being tested, 
e.g. the 16S rRNA gene.  For this purpose, gene-specific DNA oligonucleotide probes were 
designed to bind to the RNA extracted from cells grown in either erythromycin inducing 
conditions or from cells grown in normal growth conditions, to compare their transcription 
levels (Figure 3.2). 
 
Figure 3.2. RNA hybridization analysis of erythromycin induced and uninduced B. longum cells. 
The results obtained indicated that all the genes being investigated here were up-regulated in 
response to erythromycin exposure, when compared to the uninduced condition.  Since these 
genes have been proven to be functional multidrug efflux genes (Chapter 2), their up-
regulation is not surprising when they are presented with a known substrate of ABC-type 

















transporters (Margolles et al., 2005; Woebking et al., 2005).  The up-regulation of these 
genes in response to antimicrobial challenge once more strengthens their classification as 
multidrug efflux, ABC-type transporters, which contribute to the cells intrinsic resistance. 
An interesting outcome of this experiment is the moderate up-regulation of the ctr gene 
homologue BLLJ_0511, a Na+ dependent nucleoside transporter.  In Chapter 2, the RT-PCR 
analysis showed no visible increase in the transcription levels of this gene, but the use of a 
more sensitive technique such as RNA hybridization analysis shows a slight increase.  This 
gene is a proven cholate-specific transporter and has previously been shown to be cross-
induced by exposure to bile salts, leading to a increase in its resistance to erythromycin (Price 
et al., 2006).  Here it is shown that prolonged exposure of B. longum JCM 1217 cells to 
erythromycin lead to an increase in the transcriptional levels of the ABC-type transporter 
genes BLLJ_1495/4, 1837/6 and the cholate transporter gene BLLJ_0511.  These results 
indicate a probable role of these genes in erythromycin resistance since the genes being 
upregulated are proven multidrug resistance genes, belonging to the ABC-type family. No 
quantitative comparison of the spot intensities could be carried out due to the differing probe 
efficiencies for each gene.  qRT-PCR will be used to quantify the gene expression levels. 
This increase in the transcription levels of MDR transporter genes by long term exposure to 
antimicrobials is not uncommon and has previously been observed in Staphylococcus aureus 
which, when exposed to biocides and other toxic chemicals commonly used in the hospital 
environment, showed the development of mutants which had significantly increased MIC’s to 
numerous antimicrobials (Huet et al., 2008).  In Salmonella typhimurium it was observed that 
exposure to sub-inhibitory levels of antibiotics, such as erythromycin, lead to an increase in 
the transcription of various genes by the modulation of numerous bacterial promoters (Goh et 
al., 2002).  These studies correlate well with this study, showing that long term exposure to 
antimicrobials can lead to changes in the transcriptional levels of numerous genes related to 
the tolerance of the antimicrobial substance. 
 
4.3. Determination of the sub-lethal concentration of erythromycin 
Since the gradient plated method was used with several passages on increasing concentrations 
of erythromycin, the results above indicate the effect of prolonged erythromycin exposure on 















erythromycin exposure on the transcriptional levels of the genes being studied, a more 
specific exposure condition must be used.  For this purpose, growth studies were conducted 
on B. longum JCM 1217 grown in BYG broth supplemented with various concentrations of 
erythromycin, and the effect on growth was determined by measuring the change in optical 
density of the culture over time (Figure 3.3).  These conditions allowed for a direct measure 
of the impact on cell growth by a short exposure to erythromycin, and allowed for the 
determination of the sub-lethal concentration of erythromycin which produced a 
physiological response. 
The data obtained from this experiment indicated that the cells did respond to the addition of 
erythromycin, to varying degrees.  It is interesting to note that even though the basal MIC 
obtained for the gradient plate inductions was only 0.44 µg/ml, the bacteria were able to 
tolerate concentrations of 1.0 µg/ml of erythromycin, in broth cultures, when in mid-log 
phase and exhibited no significant reduction in their growth rate at these concentrations. 
 
Figure 3.3. Growth curves showing the result of erythromycin addition on the growth of B. longum JCM 1217. Error bars indicated the 


























B. longum erythromycin growth curve 
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When concentrations exceeding 2 µg/ml of erythromycin were added, the cells showed a 
marked decrease in their growth rate, as well as, in the final optical density they reached.  At 
1 µg/ml of erythromycin the final OD600 was ≈ 0.7 whereas for 2 µg/ml it only reached a final 
OD600 of ≈ 0.5.  This may have been as a result of a shift in the transcriptome of the cells by 
the induction of resistance genes which were recruited to detoxify the cell, a phenomenon 
observed for B. animalis cells in response to bile salts which lead to a shift in the 
transcriptome of the cells to tolerate the bile salts stress, which included the upregulation of 
membrane bound transporter proteins (Lin et al., 2005; Ruiz et al., 2009; Sánchez et al., 
2007).  The fact that there is no overall decrease in the optical density after this point may 
indicate a steady state where the cells are able to tolerate the added erythromycin and cell 
death is averted.  However, since no viable plating was carried out, this cannot be confirmed.  
The plating of cells on erythromycin gradient plates does however give an indication that if 
not all cells, then a group of persister cells may remain viable leading to the observed 
phenotype of a significantly more resistant population of bacteria. 
When 4 µg/ml of erythromycin was added, another marked decrease in the final OD600 
reached (≈ 0.4) compared to that obtained for 2 µg/ml, was observed.  It can be inferred that a 
maximum level of tolerance is reached at 1 µg/ml and that bacterial growth is significantly 
impaired at higher concentrations.  These results indicate a response by B. longum JCM 1217 
to erythromycin exposure as indicated by an altered growth response in its presence.  The 
sub-lethal dose of erythromycin for B. longum JCM 1217 growing in BYG broth was 
established to be 1 µg/ml and significant reduction in the growth rate was observed at 2 
µg/ml.  Using this data, the levels of gene transcription could be measured at the 
concentrations which lead to a change in the growth dynamics of the cells and any changes 
observed may be linked to the tolerance of the erythromycin. 
 
4.4. Quantitative Real Time – PCR (qRT-PCR) 
Quantitative Real Time PCR (qRT-PCR) was used to quantify the effect of erythromycin on 
the transcription of the ABC-type transporter genes being studied here.  RT-PCR experiments 
in Chapter 2 and the RNA hybridization experiments above gave a semi-quantitative 
indication that all the genes being investigated were up-regulated in response to erythromycin 
challenge.  In order to quantify the transcriptional levels of the ABC-type transporter genes of 















reflect the conditions where the transcriptome might be altered to cope with the antibiotic 
challenge.  Growth curve experiments showed that the addition of 1 µg/ml of erythromycin 
had no significant influence on the growth dynamics of mid-log B. longum cells, whereas, 2 
µg/ml of erythromycin greatly reduced the growth of the cells.  To accurately determine 
whether these cells do in fact recruit the ABC-type transporter genes under investigation here 
in response to erythromycin challenge, qRT-PCR experiments were carried out on cDNA 
produced from the total cellular RNA harvested from mid-log B. longum cells exposed to 1 
µg/ml or 2 µg/ml of erythromycin for two hours. 
Since both gene clusters being studied here are transcribed as operons (Chapter 2), this 
experiment was designed to determine the transcription levels of only the upstream gene of 
each gene cluster (BLLJ_1495 and BLLJ_1837) as an indication of the levels of gene 
transcription for the entire operon, in relation to the 16S rRNA gene.  The BLLJ_0511 gene 
was also included in this experiment to determine if cross induction of this gene also occurs 
as was previously observed to a lesser extent, in the RT-PCR and RNA hybridization 
experiments. 
TaqMan based qRT-PCR was used to quantify the gene expression levels (Holland et al., 
1991).  TaqMan qRT-PCR allows for multiplexing of reactions in qRT-PCR and does not 
produce false results associated with primer-dimer formation; it also does not require post 
reaction processing as only the correct primer-probe interaction with the template DNA 
produces a fluorescent signal (Li et al., 2003; Nazarenko et al., 2002).  DNA oligonucleotide 
primers and probes were designed to target an internal fragment of each gene of interest 
(GOI), as well as the 16S rRNA gene, as a reference gene.  To reduce the inter- and intra-
reaction variation commonly associated with qRT-PCR, the experiment was designed to be 
performed as a multiplex qRT-PCR, which would incorporate the GOI and 16S rRNA 
primer/probe sets in one reaction.  Since each GOI probe and each 16S rRNA probe was  
labelled with different fluorescent dyes, they could be carried out in the same reaction tube 
and their respective products measured separately at the same time (Nazarenko et al., 2002).  
This approach greatly reduces the technical, as well as, reaction error since both reactions are 
carried out in the same reaction environment and all conditions are exact for both 
measurements.  To test the specificity of the oligonucleotide primers designed for this 


















Figure 3.4. qRT-PCR primer specificity using standard PCR analysis. M = molecular weight marker.  Lane 1, 16S1495F/R; lane 3, 
Q1495F/R; lane 5, 16S1837F/R; lane 7, Q1837F/R; lane 9, 16S0511F/R; lane 11, Q0511F/R.  Lanes 2, 4, 6, 8, 10, 12, no template control 
for each respective primer pair. 
The results of the PCR analysis on each of the primer pairs designed for qRT-PCR 
experiments showed that a single specific amplicon of the correct size (Table 3.2) was 
produced for each reaction. 
To confirm whether a single product was produced using qRT-PCR conditions, the primer 
pairs were then tested using SYBR green based qRT-PCR (Figure 3.5) (Morrison et al., 1998; 
Vitzthum et al., 1999).  This technique allowed for the construction of a melt curve at the end 
of the reaction, which indicated the presence of all products in the reaction.   
 
Figure 3.5. SYBR green qRT-PCR analysis of primer specificity. (A) Amplification curves of individual primer pair reactions. (B) Melt 
curves of individual primer pair reactions. Type = type of sample.  Unknown = sample to be assayed.  NTC = no template control. 
The SYBR green analysis of the primers showed that during normal qRT-PCR amplification 
a single amplification curve was generated for each primer pair, when tested individually.  By 
heating the reaction products in a step-wise manner to complete denaturation, the DNA-
binding dye SYBR green, incorporated during the amplification, was released and a curve 
was constructed showing the inverse of the resulting decrease in fluorescence.  Since each 
product of varying length denatured at a different temperature, related to its length, the 
presence of non-specific products would be visualised when more than one peak is produced 
during the melt curve (Ririe et al., 1997).  The data obtained above showed that a single 
A B
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product was being specifically amplified in each reaction when genomic DNA was used as a 
template.  The resulting melt curve analysis also showed that a single product was produced 
for each primer pair and that the no template controls were well below the detectable level.  A 
shoulder was also visible in all of the primer melt curves, however, this is a common 
occurrence in SYBR green based qRT-PCR and is an indication of the formation of primer-
dimers during amplification.  This is often a problem using this technique and reduces the 
sensitivity of the measurement since all values must be normalised to account for this 
background increase in fluorescence.  This is not a phenomenon that occurs in TaqMan based 
qRT-PCR since a fluorescent signal is only produced when the probe binds to its 
complimentary DNA sequence and is subsequently hydrolysed by the DNA polymerase 
enzyme, releasing the probe-bound fluorophore (Bustin, 2000).  This data showed that the 
designed primers were specific for the DNA targets they were designed to amplify and did 
not produce non-specific products. 
Using the conditions tested thus far, multiplex qRT-PCR reactions were carried out for all the 
primer-probe sets which included the GOI and 16S rRNA primer sets.  Optimal reaction 
conditions were obtained using a 60°C primer annealing/elongation step.  Figure 3.6 shows 
the results obtained in the final multiplex qRT-PCR reactions used to quantify the gene 
expression levels of BLLJ_1837, BLLJ_1495 and BLLJ_0511.  A typical quantitation and 
standard curve is shown for each gene being quantified, as well as, the reaction data obtained 
















Figure 3.6. Data obtained for all replicates of multiplex qRT-PCR of (A) BLLJ_1837, (B) BLLJ_1495 and (C) BLLJ_0511. R2  = best fit 
regression analysis, Eff = efficiency of each reaction. 
The data above indicated that a successful amplification plot and reliable reaction data for 
each run was obtained.  The reaction efficiencies obtained were somewhat lower than those 
obtained using standard SYBR green qRT-PCR.  This is due to the multiplexing of the 
reactions using TaqMan probes to quantify the gene transcription levels.  Since two reactions 
are taking place simultaneously in the same tube the reaction efficiencies are lower since they 
may impact each other during amplification.  The efficiencies were still within the acceptable 
range and the reduction in reaction error obtained by multiplexing far outweighed the slight 
reduction in reaction efficiencies.  Based on this the levels of gene transcription for the ABC-
type transporters obtained were quantified. 
 
4.5. Quantification of transcriptional levels 
To quantify the data obtained from these experiments, it is important to take into 
consideration the difference in reaction efficiency obtained for each GOI and its respective 















of DNA amplification during each run and must be taken into consideration during analysis 
to ensure the data is relatable and to ensure there is no bias for one product or the other.   
The aim of this experiment was to determine whether the genes being investigated were 
transcriptionally up-regulated in response to erythromycin exposure.  The final answer only 
requires that the ratio of gene expression between the reference gene (16S rRNA) and the 
GOI be determined. The outcome of this is thus relative and not absolute.  The Pfaffl method 
of data analysis takes all of these criteria into account in one algorithm (Pfaffl, 2001).  This 
formula presents the ratio of gene expression of the GOI relative to the reference gene and 
incorporates the reaction efficiencies of each run in the calculation as well. 
Using the Pfaffl equation, the ratios of gene expression relative to the reference gene can be 
obtained, but this ratio does not reflect the statistical significance of the change in expression.  
To determine the statistical relevance of the data obtained as it refers to the ratios obtained 
using the Pfaffl method, further statistical analysis needed to be conducted.  Traditional 
methods for the comparison of multiple groups would involve either the use of multiple t-
tests (with appropriately adjusted p-values) or ANOVA methods (were the data normally 
distributed), or the equivalent nonparametric tests: the Wilcoxon-Rank Sum or Kruskal-
Wallis tests.  Since the ratios obtained here are non-symmetrically distributed, and are 
calculated using the Pfaffl methodology the above methods are not appropriate.  For this 
reason we adjusted the standard methodology to obtain the same ratios as those found with 
the Pfaffl method which allowed us to statistically test the data obtained.  
Since the Pfaffl method assumes a normally distributed data set, the statistical analysis must 
also be conducted using methods which apply to a normally distributed data set.  The data set 
obtained from this experiment, as is the case with most biological data, is not normally 
distributed due to the high degree of variability inherent in all living organisms.  For this 
reason, statistical relevance can only be inferred if the data set is mathematically adjusted, in 
a linear form, to generate a normally distributed version of the data set.  Using this approach 
the data is not changed since the same adjustment is equally applied to each value.   This is 
accomplished by calculating the Log10 equivalent of each value obtained.  Since the Pfaffl 
method shows the ratio of GOI/REF = A/B, and mathematically A/B =                 , 
taking the natural log of each value still gives the same ratio as does the Pfaffl method.  
When this approach is used, a normally distribute data set is obtained.  Statistical analysis 















data has not been changed and the normalisation preserves the Pfaffl ratios already 
calculated.  Using this normalised data set, a regression analysis was carried out to determine 
the average ratio obtained for each gene at each condition tested.  This regression indicated 
the statistical significance of the changes observed and were identical to those obtained using 
the Pfaffl equation and could therefore be applied here (Table 3.4). 
Table 3.4. Statistical significance, indicated by probability values, obtained from the regression analysis on the 
normalised qRT-PCR data. 
Condition BLLJ_1837 BLLJ_1495 BLLJ_0511 
1 µg/ml 0.018 0.294 0.244 
2 µg/ml 0.003 0.304 0.102 
 
This analysis showed that for both conditions tested (1 µg/ml or 2 µg/ml of erythromycin), 
only BLLJ_1837 showed statistically significant differences in gene expression.  For 
BLLJ_1837 exposed to 1 µg/ml of erythromycin, the 3.33 fold increase in gene transcription 
is statistically significant with a p-value of 0.018, and at 2 µg/ml of erythromycin, the 3.29 
fold increase in gene transcription is statistically significant with a p-value of 0.003.  Figure 
3.7 shows the changes in gene expression, during erythromycin challenge of the ABC-type 
transporter genes using the Pfaffl method of quantitation, as well as, the statistically 
significant changes obtained from the regression analysis. 
The results obtained from the multiplex qRT-PCR showed an increase in the transcription 
levels of all the genes assayed.  This correlates well with the data obtained from the RT-PCR 
in Chapter 2, as well as, the RNA hybridization analysis presented in this Chapter.  The most 
notable increase was obtained for BLLJ_1837, which exhibited greater than 3-fold increase in 
response to both 1 and 2 µg/ml of erythromycin, and is statistically significant.  There is no 
significant difference in the transcription levels of BLLJ_1837 between the two erythromycin 
concentrations tested.  This could indicate a maximum gene response at 1 µg/ml 
erythromycin.  The slight decrease observed at 2 µg/ml of erythromycin may be indicative of 
the reduction in the growth rate observed in the growth curve analysis, and strengthens the 
















Figure 3.7. Bar graph showing the fold change in the gene expression levels of BLLJ_1837, 1495, 0511 in response to erythromycin 
exposure.  Error bars represent the standard error of three independent biological replicates.  Asterisks’ indicate the statistical significance 
(*, P = 0.018; **, P = 0.003). 
 
For BLLJ_1495, the increase observed was not as dramatic, and even though it is not 
statistically significant, it was still high enough to indicate a change in transcription, in 
response to erythromycin exposure.  Once again a slight decrease was observed at 2 µg/ml 
erythromycin, this may also have indicated that a maximum in the gene expression levels 
may have been reached at 1 µg/ml and that the cells may be severely compromised at 
concentrations above that, as was observed in the growth curve experiments.  This data 
correlates well with other studies which have shown that bacteria exposed to sub-inhibitory 
concentrations of antibiotics exhibited increased levels of gene transcription, including those 
involving multidrug efflux systems (Goh et al., 2002; Huet et al., 2008; Lin et al., 2005). 
When the gene expression levels obtained here were compared to the E-test MIC levels 
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showed the inverse situation.  The MIC obtained for BLLJ_1837 and BLLJ_1495 was 0.19 
µg/ml and 0.38 µg/ml respectively.  Since the gene expression levels obtained are inversely 
proportionate to their MIC values, it again highlights the multifaceted mechanism these 
transporters play in conferring multidrug resistance.  Not only do they simultaneously confer 
resistance to multiple, structurally unrelated antimicrobial substances; they do this in a poly 
specific manner which determines to what extent they are able to bind to and subsequently 
expel these substances from the cell (Lubelski & Driessen, 2007).  Therefore, even though 
the gene expression level of BLLJ_1495 was half that of BLLJ_1837 when exposed to 1 – 2 
µg/ml of erythromycin, it still conferred a level of resistance to erythromycin which was 
double that of BLLJ_1837, when measured using the E-test method.  This may have indicated 
that BLLJ_1495 may have had an enhanced responsivity towards erythromycin and could 
thus possibly expel it to a greater extent, than could BLLJ_1837.  This may also explain the 
large error obtained in the gradient plate inductions, since whichever transporter is recruited, 
and to what extent it is used in response to antibiotic challenge, will determine the MIC at 
that concentration.  This would thus result in different values being obtained during long term 
exposure, as the cells may switch from one transporter to another depending the energy 
requirements and efficiency of each transporter. 
The increase in the gene expression levels observed for BLLJ_0511 indicates a minor 
response to erythromycin exposure.  This was observed in RNA hybridization experiments 
where a slight increase in the gene expression levels was obtained.  Even though this gene is 
specific to cholate transport it has been shown to be cross induced to a higher erythromycin 
MIC by pre-exposure to cholate (Price et al., 2006).  It is, therefore, possible that exposure to 
erythromycin may lead to a slight increase in the levels of BLLJ_0511 transcription as well.  
However, whether this increase in gene transcription levels leads to an increase in cholate 
efflux still needs to be experimentally determined.   
The presence of a putative transcriptional regulator in each gene cluster being studied 
(Chapter 2) presents another question regarding the transcription of these genes.  
Transcriptional regulators can significantly alter the transcriptional profiles of genes in 



















The experimental data presented in this Chapter gave strong evidence of the inducibility of 
these ABC-type transporter genes.  The long term exposure of the bacteria to erythromycin 
lead to a dramatic increase in the MIC with a concomitant increase in the gene expression 
levels of the genes being investigated.  Exposure of the bacteria to specific concentrations of 
erythromycin also resulted in a physiological decrease in their growth rate and a depression in 
the final population levels.  The levels of gene transcription for all the genes being studied 
also showed a marked increase in response to these specific growth conditions, which 
indicated a mechanism of directed gene up-regulation by B. longum JCM 1217, in response to 
erythromycin challenge. 
The influence of the putative transcriptional regulators identified upstream of each operon, 
warrants further investigation.  Since all of the genes in both operons being studied are 
simultaneously up-regulated in response to erythromycin exposure, it is possible that such a 
regulatory system may be responsible for the upregulation of all these resistance genes by 
simultaneously up-regulating their expression through the recruitment of individual gene-
specific regulators.  This would allow for specific and controlled induction of numerous 
genes to detoxify the cell during antibiotic exposure.  The role of the putative regulators in 
these gene clusters must thus be investigated to ascertain their roles in regulating the 
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The genome arrangement of the two gene clusters under investigation here revealed the 
presence of two putative MarR-type transcriptional regulators upstream of the ABC-type 
transporter genes being investigated.  This Chapter presents the first evidence of the possible 
transcriptional regulation of bacterial gene expression in B. longum JCM 1217 by a MarR-
type regulator.  Both of the putative regulators, BLLJ_1496 and BLLJ_1838, were cloned and 
expressed in the soluble fraction of E. coli BL21pLysS (DE3) cells.  Using these purified 
proteins in electrophoretic mobility shift assays, it was shown that the BLLJ_1496 protein 
bound stably, specifically and with high affinity to a single DNA fragment upstream of the 
operon, even in the presence of sodium salicylate (a known inhibitor of MarR protein 
binding) and when presented with other potential DNA targets.  The role of erythromycin as 
an effector molecule was also investigated, but showed no significant function in disrupting 
the observed regulator binding.  The purified protein, BLLJ_1838, did not exhibit any 




The regulation of gene expression at the transcriptional level is a vital mechanism employed 
by all organisms to facilitate control of cellular energy and resources.  Unorganised or 
unnecessary expression of genes would deplete cellular resources and lead to cell death.  
Since most prokaryotes rely on fluctuating external energy sources, tight control is needed to 
prevent wastage of important cellular reserves.  One of the most efficient mechanisms in 
regulating gene expression at a transcriptional level involves the use of regulatory proteins 
binding to DNA to up- or down-regulate gene expression in response to various stimuli 
(Huffman & Brennan, 2002).  Since membrane proteins underpin the structure of the cell 
wall, it is vital to control the amount of various proteins present in the phospholipid bilayer 
comprising the bacterial cell membrane.  ABC-type multidrug efflux transporters are integral 
membrane proteins and are only required when active transport of specific compounds is 
needed.  Their expression thus requires tight regulation with prompt response with changing 















The transcriptional regulation of multidrug resistance pumps is not uncommon and, in 
particular, ABC-type efflux transporters have been shown to be regulated by MarR-type 
regulators (Lubelski & Driessen, 2007; Putman et al., 2000).  MarR-type regulators are 
negative transcriptional regulators which down-regulate gene expression when bound to 
palindromic or pseudopalindromic sequences upstream of structural genes and may also auto-
regulate their own production (Wilkinson & Grove, 2001).  In Chapter 2 of this study, two 
putative transcriptional regulator proteins (BLLJ_1838 and BLLJ_1496) were identified 
upstream of the two operons being studied here using the genome sequence of B. longum 
JCM 1217 obtained from the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov).  The gene annotation data for this bacterium classifies 
BLLJ_1496, part of the three gene operon identified in Chapter 2, as a transcriptional 
regulator belonging to the GntR family of regulators, classified by a helix-turn-helix domain.  
This family of regulators has also been shown to regulate the transcription of ABC-type 
transporters (Hillerich & Westpheling, 2006; Rigali et al., 2002).  The second putative 
regulator, BLLJ_1838, upstream of the two gene operon identified, is classified as a 
transcriptional regulator with no family classification stipulated.  Based on their sequence 
homology to other transcriptional regulators, these two putative transcriptional regulators do, 
however, resemble the MarR family of transcriptional regulators, most closely.  Their 
potential for regulating the ABC-type multidrug efflux genes downstream is investigated in 
this Chapter.   
An important first step in proving gene regulation by DNA binding proteins is to show the 
proposed binding reaction in vitro.  Specific binding of a regulator to a DNA sequence 
implies a role in regulating the genes that follow.  Experimental techniques such as x-ray 
crystallography and DNase footprinting are technically demanding and rely on DNA 
labelling with radioactive molecules, as well as, running complex sequencing electrophoresis 
gels (Martin & Rosner, 1995).  Electrophoretic mobility shift assays (EMSA) offer a simpler 
and less toxic approach, and allow for the indirect identification of the DNA-protein 
interaction as a retardation of the DNA mobility in a native polyacrylamide gel when bound 
to a protein (Martin & Rosner, 1995). 
In this chapter we investigate the binding of the two putative transcriptional regulator 
proteins, BLLJ_1496 and BLLJ_1838, to proposed target DNA sequences, using EMSA.  
The classification of BLLJ_1496 as a member of the MarR-type family of regulators, as 















3. Methods and Materials 
3.1. Bacterial strains and media and plasmids 
Escherichia coli DH5α cells were propagated in Luria-Bertani broth at 37 °C with lateral 
shaking (Sambrook & Russell, 2001).  Agar (Merck) was incorporated into broth media at a 
concentration of 1.5% (w/v) for plating. When necessary, Ampicillin (Amp) was used at 
50 μg ml-1, Chloramphenicol (Chl) at 34 μg ml-1 (Sigma-Aldrich), IPTG at 1 mM and X-gal 
at 50 μg ml-1 (Bioline). 
3.2. Preparation and manipulation of DNA 
Plasmid DNA was routinely isolated from E. coli DH5α using the alkaline lysis method (Ish-
Horowicz & Burke, 1981).  Plasmid DNA for use in cloning or sequencing was isolated from 
E. coli DH5α cells using the EZNA
 
Plasmid Miniprep Kit (Peqlab Biotechologie GmbH) as 
per the manufacturer’s protocols.  E. coli DH5α competent cells were prepared by CaCl2 
treatment and transformed using the heat shock approach (Dagert & Ehrlich, 1979).  
Chromosomal DNA was extracted from B. longum JCM 1217 cells as described in Chapter 2.  
DNA fragments were routinely analysed by electrophoresis through either 0.8% (w/v) or 2.0% 
(w/v) agarose gels in TAE buffer (40 mM Tris-acetate, 0.5 mM EDTA), visualised using 
ethidium bromide staining and a Gel Doc-XR UV System (Bio-Rad) and, when required for 
cloning, purified using the Biospin PCR Purification Kit (Bioflux).  Lambda bacteriophage 
DNA (Promega) digested with PstI was routinely used as a DNA molecular size marker.  
DNA quality and concentration were measured with a ND-1000 spectrophotometer 
(NanoDrop Technologies).  Restriction digests and ligations were performed according to 
standard methods (Sambrook & Russell, 2001).  All restriction enzymes were obtained from 
Fermentas.  DNA samples were stored at - 20 °C in sterile dH2O. 
3.3. DNA amplification using the polymerase chain reaction and DNA sequencing 
Polymerase chain reaction (PCR) mixtures (50 μl) typically consisted of (final concentrations 
indicated in parentheses): 2 μl B. longum genomic or plasmid template DNA (4 ng μl-1), 2.5 
μl of each primer (0.5 μM), 25 μl of 2 × KAPATaq ReadyMix (10 mM Tris-HCl [pH 8.6], 
50 mM KCl, 0.05% [v/v] Tween 20, 0.5 mM DTT, 5% [v/v] glycerol, 1.5 mM MgCl2, 1.25 U 
KAPATaq and 0.2 mM of each dNTP) (Kapa Biosystems) and 18 μl of sterile dH2O. The 















(Applied Biosystems) or an Advanced Primus 25 Thermal Cycler (Peqlab Biotechologie 
GmbH).  DNA fragments used for EMSA were amplified using KAPATaq Readymix.  To 
PCR amplify target DNA for protein expression, the High Fidelity PCR System (Fermentas) 
was used. 
The identities of the purified target DNA fragments for EMSA were verified by DNA 
sequencing.  For protein expression, the DNA fragments were first ligated into pET22b (+) 
(Novagen), transformed into DH5α cells and the plasmids harvested and purified before 
submitting for sequencing.  The reaction products were sequenced by Macrogen (South 
Korea) and the sequence data analysed using the BLAST algorithm at NCBI. 
3.4. Cloning and protein expression 
 To construct a system where the putative regulator proteins could be over-expressed for 
EMSA, the open reading frames encoding the genes BLLJ_1838 and BLLJ_1496 were PCR 
amplified using HiFi Taq (Fermentas) and the primers in Table 4.1, from genomic DNA 
isolated from B. longum JCM 1217.  The primer pairs (Table 4.1) contained restriction 
enzyme sites to facilitate cloning into, as well as, re d-through for the incorporation of the 
histidine tag at the 3’ end of the pET22b (+) expression vector.  The resulting PCR products 
were digested with the relevant enzymes and then ligated into the pET22b (+) expression 
vector digested with the same enzymes and transformed into competent E. coli DH5α cells.  
The resulting plasmid DNA was harvested and the constructs confirmed for the presence of 
the correct insert DNA by DNA sequencing. The constructs containing the correct DNA 
fragments were retransformed into the competent expression host cells, E. coli BL21 (pLysS) 
(Novagen). 
3.5. Over-expression and purification of recombinant proteins 
To produce sufficient quantities of recombinant protein for EMSA, the two recombinant 
putative regulator proteins were over-expressed as per the pET System Manual (Novagen).  
The following changes were made to facilitate soluble protein production: a 10 ml pre- 
culture of E. coli BL21 (pLysS) expressing either the recombinant protein BLLJ_1838 or 
BLLJ_1496 was grown overnight with Amp and Chl and was then used to inoculate 500 ml 
of LB broth containing Amp and Chl.  The culture was grown aerobically at 37 °C with 
lateral shaking in a baffled flask and the optical density measured until an OD600 ≈ 0.6 was 















was further incubated for 4 hours at the same conditions to allow for protein production.  The 
cells were harvested by centrifugation (20 min, 4000 x g, 4 °C).  Cell pellets were stored at -
20 °C for up to 18 hours when necessary. 
Protein purification of the expressed proteins as accomplished using the HIS-Select nickel 
affinity agarose column (Sigma-Aldrich).  Cell pellets were resuspended in 10 ml 
equilibration/wash buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM Imidazole, pH 8.0 with 
NaOH) (Sigma).  Lysozyme (Sigma) was added to a final concentration of 1 mg.ml-1 and the 
mixture was incubated on ice for 30 min.  Cells were disrupted by sonication using the 
microtip on the Virsonic Digital 600 sonicator (Virtis) with the following program: 5 min (30 
sec pulse, 20 sec cooling in an ice-alcohol bath) at Level 3 power output.  The resulting lysate 
was clarified by centrifugation (30 min, 10 000 rpm, 4 °C).  The supernatant was loaded onto 
a prepared Ni+ affinity column as per the manual instructions (Sigma).  The bound column 
was washed with approximately 50 ml of equilibration/wash buffer and the remaining bound 
protein was eluted using 5 ml elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM 
Imidazole, pH 8.0 with NaOH) (Sigma), and stored at -80 °C.  The eluted protein was 
quantitated using Coomassie Brilliant Blue G-250 dye (Bio-rad) and Bovine Serum Albumin 
(Fermentas) for the construction of a calibration curve (Bradford, 1976). 
Prior to electrophoretic separation, protein samples were denatured in the presence of an 
equal volume of loading buffer (125 mM Tris-HCl [pH 6.8], 2.5% [w/v] SDS, 20% [v/v] 
glycerol, 0.2 % [w/v] bromophenol blue) by heating at 100 °C for 5 min.  Proteins were then 
separated according to molecular weight by SDS-polyacrylamide (37:1) gel electrophoresis 
(PAGE) using a Mini-PROTEAN Electrophoresis System (Bio-Rad) with a 6% stacking gel 
and a 15% resolving gel as described by (Laemmli, 1970).  The prestained PageRuler protein 
molecular weight marker (Fermentas) was used to determine the apparent molecular weights 
of the separated proteins.  Hexahistidine-tagged proteins were detected according to the 
standard Western blot method using an anti-6-His rabbit antibody (1:5000 dilution) and a 
horse radish peroxidise-conjugated anti-rabbit goat secondary antibody (1:5000 dilution) in 
conjunction with the chromogenic TMB membrane peroxidase substrate (all manufactured by 

















Table 4.1. Primer sequences and features for putative regulator cloning and EMSA DNA targets 
 
3.6. Electrophoretic mobility shift assays (EMSA) 
For EMSA visualisation, the target DNA fragments were 3’ labelled with a DIG-molecule 
using the DIG Gel Shift Kit, 2nd Generation (Roche) by means of PCR amplification using 
the primer pairs in Table 4.1.  The fragments were gel excised, purified and confirmed with 
DNA sequencing.  A typical labelling reaction was performed as follows: 3.85 pmol DNA in 
10 µl TEN buffer (10 mM Tris, 1 mM EDTA, 0.1 M NaCl, pH 8.0) was heated to 95 °C for 
10 min then cooled to 20 °C for 2 min.  4 µl 5 X Labelling buffer (1 X), 4 µl CoCl2 solution, 
1 µl DIG-ddUTP solution, 1 µl Terminal Transferase was then added to the DNA to a final 
volume 20 µl.  The mixture was incubated at 37 °C for 15 min after which 2 µl of 0.2 M 
EDTA pH 8.0 (2 mM) as added to stop the reaction.  The final reaction volume was adjusted 
to 25 µl by adding 3 µl of sterile dH2O and the labelled DNA was stored at -20 °C. 
To determine whether binding of the putative regulator proteins to their target DNA 
sequences had occurred, a binding reaction was conducted in vitro to mimic the in vivo 
reaction.  Protein DNA-binding reactions were prepared on ice using the DIG Gel Shift Kit, 
2nd Generation (Roche).  A 20 µl reaction typically included 4 µl of 5 X binding buffer (100 
mM HEPES [pH 7.6], 5 mM EDTA, 50 mM (NH4)2SO4, 5 mM DTT, 1% [w/v] Tween 20, 
150 mM KCl).  Poly-(d[I-C]) and poly-L-lysine solutions were added (1 µg.µl-1 each).  
Finally, 2 µl labelled DNA (3.1 fmol) and 3 µg purified protein were added and the reaction 
volume adjusted to 20 µl with sterile dH2O.  The reaction mix was incubated at 25 °C for 15 
Primer name Primer Sequence (5’ – 3’) Purpose Features Size 
BLLJ_1838PEF GGAATGGATGGTGCTCACATGTTATTTGAG Expressing 
BLLJ_1838 
PstI restriction site 
563 bp 
BLLJ_1838PER GCCAGCGGGAGGAAGCTTGTCTCGCTC HindIII restriction site 
BLLJ_1496PEF CGGAGGACCATGGATCAGC Expressing 
BLLJ_1496 
NcoI restriction site 
555 bp 
BLLJ_1496PER CTGCGGTATCTCGAGTTCG XhoI restriction site 
BL1518F CAGGAAGATCTATATCGGCACCATCGCGTTC BL1518  
promoter region 
(Klijn et al., 2006) 291 bp 
BL1518R GCTGCCCTCGAGCATATTGTCTCCTTCGAC 
BLLJ_1839GF TGTCTTCATCCGCCTTTTCGACC EMSA 





BLLJ_1838GF AGCGCGCGGAGAACTAATCGG EMSA 
DNA Target 3 




BLLJ_1837GF TCAGCCAGTCGGAGCTTACGG EMSA 





BLLJ_1497GF TGGTTGACGAGTACGCCAAGC EMSA  



















min, and then placed on ice.  Varying concentrations of erythromycin (1, 5, 10, 20, 50, 100 
mM) and Na-salicylate (0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 1.2 M) (Sigma) were tested for 
their potential to inhibit binding. 
3.7. Native Polyacrylamide Gel Electrophoresis 
Protein DNA-binding reactions were analyzed by running on a native 6% (w/v) 
polyacrylamide gel (30%, 29:1 acrylamide mix; Sigma-Aldrich; 0.25 × TBE buffer; 0.1% 
APS; 0.1 % TEMED) at 100 V using a Mini-PROTEAN Electrophoresis System (Bio-Rad) at 
4 °C.  Prior to the separation of unbound DNA and DNA-protein complexes by native PAGE, 
2.5 µl of loading buffer (0.25 × TBE buffer [22.25 mM Tris-borate, 0.5 mM EDTA], 60% 
[w/v] glycerol, 0.2% [w/v] bromophenol blue) was added to each reaction.  Prior to loading, 
native PAGE gels were pre-run for 1 hr at 100 V.  Experimental gels were typically run for 
approximately 2 hrs until the loading dye had run off the bottom of the gel.  The binding 
reactions were then transferred from the native polyacrylamide gels to a Hybond-N+ nylon 
membrane (Amersham Biosciences) via electroblotting (DIG 2nd Generation Gel Shift Kit 
manual), and then UV-crosslinked.  Transferred labelled nucleic acid was finally visualised 
using the chemiluminescent CSPD substrate (Roche) as outlined in the DIG Application 
Manual for Filter Hybridisation (Roche). 
 
 
4. Results and Discussion 
4.1. Bioinformatics 
The bioinformatic analysis of the two ABC-type multidrug efflux transporter gene clusters 
being studied here was reported in Chapter 2 of this thesis.  Upon closer inspection of these 
clusters in B. longum NC27705, the presence of two putative MarR-type transcriptional 
regulators upstream of both of the selected efflux gene clusters was noted.  When compared 
to their homologues in B. longum JCM 1217 the same genome arrangement was observed, 


















Figure 4.1. Genome arrangement of both B. longum JCM 1217 gene clusters in this study, showing the position of the putative 
transcriptional regulator genes relative to their adjacent genes. 
Since BLLJ_1838 was annotated in the genome as a ‘transcriptional regulator’ with no family 
classification, whereas BLLJ_1496 is annotated as belonging to the GntR family of 
transcriptional regulators in the B. longum JCM 1217 genome sequence at NCBI, further 
bioinformatic analysis was conducted to confirm their identities.  A BLASTP search was 
done against all prokaryote genomes in the BLAST database (Altschul et al., 1997).  The 
results showed that both putative regulators had very high similarities to other putative MarR-
type regulators (Appendix Table A4.1 and A4.2).  When a multiple protein sequence 
alignment (DNAMAN, Version 4.13, Lynnon Biosoft) was carried out using the top five 
BLASTP results, it was observed that the their combined sequence identity was > 95 % for 
BLLJ_1496 and > 91 % for BLLJ_1838 (Appendix Figure A4.1 and A4.2). 
To further investigate the classification of these proteins, more reliable bioinformatic analysis 
was carried out.  The GntR family of transcriptional regulators are characterised by their 
helix-turn-helix (HTH) domain which is known to be a tertiary protein structure used for 
DNA binding (Pabo & Sauer, 1992).   The MarR family of transcriptional regulators are 
characterised by DNA binding with a winged-helix-turn-helix (WHTH) domain (Wilkinson 
& Grove, 2001).  A multiple protein sequence alignment was constructed, using ClustalW, of 
BLLJ_1496 and BLLJ_1838 with the proven MarR regulators: MarR from Escherichia coli, 
MprA from E. coli, MexR from Pseudomonas aeruginosa and SlyA from Salmonella 
tyhphimurium.  The results of this alignment showed that there was a 26.87% overall 
sequence identity for BLLJ_1496 (Figure 4.2 A) and a 23.82% overall sequence identity for 



















Figure 4.2. ClustalW multiple sequence alignment of (A) BLLJ_1496 and (B) BLLJ_1838 with known MarR-type proteins. Secondary 
structure annotations adapted from (Alekshun et al., 2001).  Residues that are identical in all homologues are coloured blue and similar 
residues are coloured green.  The MarR secondary structure elements are illustrated as boxes for the α-helices (α), arrows for the β-sheets (β) 
and the single winged region as a line (W1).  The red asterisks below the sequence designate residues identified from the MarR crystal 
structure to form the hydrophobic core of the monomeric DNA binding domain. 
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The multiple sequence alignment of BLLJ_1496 with four functionally proven MarR 
regulators shows 8 identical residues (90, 103, 109, 111, 117, 118, 148, 152) in the C-
terminal half of the proteins.  The helix-turn-helix domain is formed by the helices α-3 and α-
4 and the 4 residues between them.  This is then flanked by the “wing motif” comprising β-2, 
W1 and β-3.  Of the identical residues, 1 (residue 90) occurs in the α-4 helix, known as the 
recognition helix for DNA binding and which makes physical contact with the DNA.  The 
next 5 identical residues (103, 109, 111, 117, 118) occur in the wing motif of MarR, and of 
the final two identical residues, 1 (148) occurs just before and 1 (152) inside the final α-6 
helix.  Of the 14 residues comprising the hydrophobic core of MarR, 6 are conserved and 1 is 
identical in BLLJ_1496 (Gajiwala & Burley, 2000; Huffman & Brennan, 2002).  Based on 
this and the strong similarity between BLLJ_1496 and other proven MarR regulators, as well 
as the presence of the wing motif, it seems highly probable that BLLJ_1496 is in fact a 
MarR-type transcriptional regulator, as it is annotated in the genome sequence of B. longum 
NC27705, and not a GntR-type regulator as it is annotated in B. longum JCM 1217, since 
GntR-type regulators lack the ‘wing motif’. 
The analysis of BLLJ_1838 does not present such compelling evidence that it is a MarR-type 
regulator.  Most notably is the absence of the wing motif in BLLJ_1838.  The helix-turn-helix 
structure appears to exist, but there is a gap where the β-2 and W1 regions exist in the MarR 
structure.  There are only 2 identical residues in the entire sequence analysis, of which only 
residue 118 lies in the tail end of the β-3 sheet region.  Of the 14 hydrophobic core residues 
in MarR, only 3 are conserved and 1 is identical.  This analysis suggests the possibility for 
DNA binding using the HTH motif, and possibly gene regulation, but it does not favour 
reclassification of BLLJ_1838 as a MarR-type regulator protein. 
Based on these analyses it was decided that EMSA would be conducted, using the purified 
proteins BLLJ_1496 and BLLJ_1838, to determine whether they were able to specifically 
bind to cognate DNA sequences flanking these putative regulators and the structural genes 
downstream.  Binding of these regulator proteins to these DNA sequences would suggest a 






















4.2. Protein expression and purification 
Purified proteins are preferred for electrophoretic mobility shift assays (EMSA) since they 
produce less background interference, as well as, greatly reduce the possibility of false 
positive results.  For this reason, both putative regulator proteins were cloned and expressed, 
using the pET Expression System (Novagen).  Optimum expression of the 19.8 kDa, histidine 
tagged BLLJ_1838 protein in the soluble fraction was obtained after expressing for 2 – 4 
hours after induction with 1mM IPTG (Figure 4.3). 
  
(a)     (b)  
Figure 4.3. SDS PAGE of BLLJ_1838 expression after 2 hours of IPTG induction. Lanes 1 and 5, total cell protein; lanes 2 and 6, 
periplasmic fraction; lanes 3 and 7, soluble fraction; lanes 4 and 8, insoluble fraction; M, molecular weight marker. (a) pET22b without 
insert, (b) pET22b containing BLLJ_1838.  Lanes 1-4, no IPTG added; lanes 5-8, 1mM IPTG added. 
 
Optimum expression of the 23.1 kDa, histidine tagged BLLJ_1496 protein in the soluble 
fraction was obtained by expressing for 4 – 6 hours after induction with 1mM IPTG     
(Figure 4.4). 
 
(a)     (b)  
Figure 4.4. SDS PAGE of BLLJ_1496 expression after 6 hours of IPTG induction. Lanes 1 and 5, total cell protein; lanes 2 and 6, 
periplasmic fraction; lanes 3 and 7, soluble fraction; lanes 4 and 8, insoluble fraction; M, molecular weight marker. (a) pET22b without 
insert, (b) pET22b containing BLLJ_1496.  Lanes 1-4, no IPTG added; lanes 5-8, 1mM IPTG added. 
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The addition of the C-terminal hexahistidine fusion tag allowed for purification by affinity 
chromatography.  The N-terminal PelB leader sequence provides the potential for periplasmic 
re-localisation of recombinant protein in E. coli BL21 (DE3) cells if needed (Georgiou & 
Segatori, 2005; Wolfe et al., 1983).   
Once both proteins were optimally expressed in the soluble fraction they were purified using 
a Ni+ Affinity column (Roche) and detected using an anti-Histidine Western blot.  The blot 
showed that the correct proteins were bound and eluted off the Ni+ affinity column (Figure 
4.5). 
 
(a)                    (b)  
Figure 4.5. Anti-His Western blot of purified proteins. (a) BLLJ_1838 anti-histidine western blot, (b) BLLJ_1496 anti-histidine Western 
blot. Lane 1, total cell protein after IPTG induction; lane 2, cleared lysate after column binding; lane 3, wash buffer; lane 4, 5, 6(b), elution’s 
1, 2 and 3 respectively. 
 
The protein expression and purification results clearly show that both putative regulators 
BLLJ_1838 and BLLJ_1496 were successfully purified from the total cellular protein milieu.  
All of the SDS-PAGE gels run for these experiments produced a doublet at the expected size, 
as well as, bands at increasing increments of double the expected protein size.  Previous work 
on MarR-type regulators has shown that these regulators act as homodimers on their target 
DNA comprising two molecules of protein for every binding site (Alekshun et al., 2001).  
This would explain the presence of bands at approximately double the expected protein size, 
as in vitro the purified proteins would be able to dimerise in a repeating manner.  To confirm 
this, another SDS-PAGE gel was run which included β-mercaptoethanol, which resolves 
quaternary proteins structures.  The resulting gels clearly show the resolution of these bands 
into one band of the correct size (Figure 4.6). 
 
 






















(a)                   (b)  
Figure 4.6. SDS-PAGE of purified the proteins (a) BLLJ_1838, (b) BLLJ_1496. Lane 1, purified protein without β-mercaptoethanol; lane 2, 
purified protein with added β-mercaptoethanol. 
 
4.3. Electrophoretic mobility shift assays (EMSA) 
EMSA was used to determine whether regulation of the two operons under investigation is in 
fact controlled by the putative regulators identified upstream of each one.  Binding of a 
regulator protein to a DNA sequence upstream of a structural gene gives a strong indication 
of a regulatory function on that gene.  To ascertain whether this is the case here, the 
BLLJ_1838 and 1496 genes were cloned, the proteins expressed and purified and were used 
in in vitro binding experiments. 
To determine whether binding occurs, the purified proteins must be presented with possible 
target DNA sequences.  DNA targets of approximately 250 – 300 bp upstream of each 
putative regulator as well as regions between the regulators and the structural genes in the 
operons were selected as putative regulator binding sites (Figure 4.7).  Since MarR-type 
transcriptional regulators bind to promoters or just upstream of promoter regions (Martin & 
Rosner, 1995), these DNA target sequences were PCR amplified, gel excised and DIG-
labelled for EMSA experiments. 
 
Figure 4.7. Figure showing the regions of DNA targeted in EMSA experiments. The numbers 1 – 4 indicate the various DNA target 
fragments, PCR amplified for EMSA.  Numbering corresponds to the primer pairs in Table 4.1. 






















Based on the bioinformatic analysis and genome arrangement of the operon BLLJ_1496-5-4 
the only probable DNA binding region for the putative transcriptional regulator was the 
region of DNA upstream of the 3-gene operon (Figure 4.7, region 1).  When the purified 
BLLJ_1496 protein was added to this target DNA a notable shift in the migration of the 
bound DNA was observed when run on a native PAGE gel (Figure 4.8).  Poly-(d[I-C]) and 
poly-L-lysine, which have been shown to reduce non-specific DNA-protein interactions and 
enhance the stability of various DNA-protein interactions were included in all the binding 
reactions (Kozmík et al., 1990). 
 
 
DNA Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 
Protein - 0.2 µg 0.4 µg 0.6 µg 0.8 µg 1.0 µg 2.0 µg 3.0 µg 1.0 µg 2.0 µg 
Comp - - - - - - - - 100 ng 100 ng 
 
Figure 4.8. Native PAGE gel of EMSA of BLLJ_1497-6 Target 1 DNA fragment with purified BLLJ_1496 protein. Lane 1, BLLJ_1497-96 
DIG labelled DNA, lanes 2-8 labelled DNA with increasing amounts of purified BLLJ_1496 protein.  Lanes 9 and 10, same as 6 and 7 
except with 100 ng unlabelled DNA added as competitor (Comp). 
The binding of the protein to the target DNA fragment and subsequent reduction in mobility 
observed above proved to be concentration dependent and at high concentrations (2 – 3 µg) 
of added protein, a “super-shift” is observed (lanes 7 and 8).  This super-shift may indicate 
the presence of a second binding site in this region, which is commonly observed for MarR-
type DNA-protein binding reactions (Martin & Rosner, 1995).  Binding of the putative 
regulator protein BLLJ_1496 to this region of DNA, as well as the ‘super-shift’ observed 
here gives a strong indication that this may in fact be the transcriptional regulator of this 
operon, and that BLLJ_1496 may well belong to MarR family of transcriptional regulators, 
based on the observed ‘super-shift’. 
For the operon BLLJ_1837-6, based on the bioinformatic analysis and genome arrangement, 
several candidate DNA regions for regulator binding are possible.  The region upstream of 





















the putative regulator (Figure 7, region 2) would be the most likely candidate based on the 
binding observed for BLLJ_1496 to the DNA fragment upstream of the operon, but, the 
region between the putative regulator and the two gene operon downstream (Figure 7, region 
3), as well as, the region between the two structural genes in the operon (Figure 7, region 4) 
cannot be ignored as potential regulator binding sites.  For this reason an EMSA was carried 
out using the purified BLLJ_1838 putative transcriptional regulator protein and target regions 
from all these selected regions of DNA (Figure 4.9). 
 
 
DNA Target 2 Target 2 Target 2 Target 3 Target 3 Target 3 Target 4 Target 4 Target 4 
Protein - 3.0 µg 3.0 µg - 3.0 µg 3.0 µg - 3.0 µg 3.0 µg 
Comp - - 100 ng - - 100 ng - - 100 ng 
 
Figure 4.9. PAGE gel of EMSA of BLLJ_1839-8 Target 2, 38-7 Target 3 and 37-6 Target 4 DNA fragments with purified BLLJ_1838 
protein. 
No binding was observed for this putative regulator protein with any of the proposed DNA 
targets using the in vitro conditions tested.  Based on this it is unlikely to be involved in 
regulating its own transcription or the two gene ABC-type transporter operon downstream.  
Further experiments should be conducted using conditions which mimic the in vivo 
conditions more accurately, such as changing the ionic profile used, as well as, the use of 
other stabilising adjuncts, to conclusively rule out the involvement of this protein in 
regulating the transcription of these genes.  It is also not possible to infer any family 
classification of the putative regulator since no functional relationship has been proven here, 
even though the BLAST analysis showed that it has > 91% similarity to other MarR-type 
transcriptional regulators. 
While binding of the putative MarR-type regulator BLLJ_1496 to the target DNA sequence 
upstream of the operon has been demonstrated here (Figure 4.8), it is important to show that 
this binding is specific for the target sequence presented and that the regulator does not bind 

















to any possible promoter region.  To confirm the specificity of this regulator’s binding, the 
reactions were repeated with target DNA obtained by PCR amplifying a region of DNA from 
B. longum JCM 1217 which includes a proven functional promoter sequence in B. longum 
NC27705 (Klijn et al., 2006).  Purified BLLJ_1496 protein was added to this DNA using the 
same conditions which produced the successful binding reaction.  We also tested the purified 
BLLJ_1838 protein in this experiment to determine its specificity even though it did not bind 
to any of the likely target DNA sequences presented before (Figure 4.10). 
 
 
DNA BL1518 BL1518 BL1518 BL1518 BL1518 BL1518 BL1518 BL1518 
Protein - BLLJ_1496 BLLJ_1496 BLLJ_1496 - BLLJ_1838 BLLJ_1838 BLLJ_1838 
Comp - - BL1518 Target 1 - 100 ng BL1518 Target 2 
 
Figure 4.10. Native PAGE of EMSA with a proven promoter region as DNA target. Lanes 1-8 contain BL1518 labelled DNA; lanes 2-4, 3 
µg BLLJ_1496 purified protein; lanes 6-8, 3 µg BLLJ_1838 purified protein; lanes 3 and 7, unlabelled BL1518 DNA; lane 4, unlabelled 
BLLJ_1497-6 DNA as competitor; lane 8, unlabelled BLLJ_1839-8 DNA as competitor (Comp). 
Since no binding was observed in any of these reactions it can be concluded that the binding 
of BLLJ_1496 to the Target 1 DNA sequence is specific and it is, therefore, most probably 
the regulator of this operon.  Functional regulator studies, where the regulator protein is 
expressed in vivo with the ABC-type transporter genes, are required to conclusively prove 
this.  For the putative regulator BLLJ_1838, no binding was observed for any of the target 
DNA sequences provided, including that of the control promoter region, this leads to the 
conclusion that it is most likely not the regulator of the operon downstream.  It also did not 
bind to the control DNA form the proven promoter region, even though it possesses the HTH 
motif for DNA binding. 
Another question that arises regarding binding specificity of these regulators is whether they 
are specific for regulating only the gene expression of their own gene clusters, or whether 
they are able to bind to and regulate other cognate ABC-type transporter genes.  Since MarR-

















type regulators are part of a regulon in E. coli and S. typhimurium (Alekshun & Levy, 1997), 
they may recognise similar binding sites for other promoters included in this regulon.  To 
ascertain whether this occurs, with these regulator proteins, in B. longum JCM 1217, an 
EMSA was conducted where the purified proteins were presented with the target DNA 
fragments of the alternate operon being studied (Figure 4.11). 
 
 
DNA Target 2 Target 2 Target 2 Target 3 Target 3 Target 3 Target 1 Target 1 
Protein - BLLJ_1496 BLLJ_1496 - BLLJ_1496 BLLJ_1496 BLLJ_1838 BLLJ_1496 
 
Figure 4.11. Native PAGE of EMSA testing cross binding. Lanes 1-3 contain BLLJ_1839-8 labelled DNA; lanes 4-6 contain BLLJ_1838-7 
labelled DNA; lanes 7 and 8 contain BLLJ_1497-6 labelled DNA; lanes 2, 3, 5, 6, 8, contain 3 µg purified BLLJ_1496 protein; lane 7, 
contains 3 µg purified BLLJ_1838 protein. 
The data obtained from this experiment reaffirms the previous results which showed that the 
binding of the regulator protein BLLJ_1496 to its target DNA fragment was highly specific 
and that even when presented with another DNA fragment upstream of another ABC-type 
transporter, no binding was observed.  If BLLJ_1496 is indeed a MarR-type transcriptional 
regulator, it shows that even though MarR-type regulators are part of a global regulatory 
system in other bacteria, the binding of the regulator tested here was highly specific for its 
respective DNA sequence.  This binding specificity would allow the cell to tightly control 
which operons are upregulated in response to challenge by external stimuli even though a 
global response may be initiated. 
Since MarR-type regulators are classified as negative transcriptional regulators, initiation of 
gene transcription would require the presence of an inducer molecule to de-repress the 
regulatory function of these proteins.  Sodium salicylate is a molecule previously shown to 
disrupt binding of MarR-type transcriptional regulators to their cognate DNA sequences, thus 
inducing gene expression (Martin & Rosner, 1995; Saridakis et al., 2008).  To investigate 
further whether the putative regulator protein BLLJ_1496 may belong to the MarR-type 

























DNA Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 
Protein - 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 
Na-Sal - 0.01 M 0.02 M 0.05 M 0.1 M 0.2 M 0.5 M 1.0 M 1.2 M 
 
Figure 4.12. Native PAGE of EMSA with sodium salicylate. Lanes 1-9 contain BLLJ_1497-6 labelled DNA with lanes 2 – 9, 3 µg of 
purified BLLJ_1496 protein; lanes 2-9 have increasing concentrations of sodium salicylate. 
The results obtained showed that sodium salicylate ppeared to have a moderate effect on 
regulator binding, since, the shifted bands decreased in intensity only when very high 
concentrations (1 and 1.2 M) were added.  This indicated that sodium salicylate had little 
effect on disrupting the regulator binding observed in its absence (Nichols et al., 2009).  It 
may also indicate the high affinity with which the protein bound to the DNA since it was not 
easily displaced by exposure to sodium salicylate. 
In the work presented in Chapters 2 and 3 of this thesis it was noted that the exposure of B. 
longum JCM 1217 to sub-lethal concentrations of erythromycin resulted in an increase in the 
transcription levels of genes downstream of the MarR-type transcriptional regulator 
BLLJ_1496.  This raises the question as to whether erythromycin might act as an effector 
molecule, and as such, whether it might have any effect on disrupting the regulator’s ability 
to bind to the target DNA sequence, thereby inducing transcription of the structural genes 
downstream.  To test this hypothesis we conducted another EMSA using the Target 1 DNA 
fragment with 3 µg of the purified BLLJ_1496 protein, with the addition of various amounts 
of erythromycin (Figure 4.13). 
 
 






















                       
DNA Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 Target 1 
Protein - 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 3 µg 
Ery - - 1 mM 5 mM 10 mM 20 mM 50 mM 100 mM EtOH 
 
Figure 4.13. Native PAGE of EMSA with erythromycin. Lanes 1-9 contain BLLJ_1497-6 labelled DNA and 3 µg of purified BLLJ_1496 
protein; lanes 3-8 have increasing concentrations of erythromycin.  Lane 9, 5 µl of 70 % EtOH as vehicle control. 
The results showed no discernible reduction in binding efficiency, but rather the opposite in 
that an increase in the binding efficiency appears to occur in the presence of erythromycin.  
However, this is an artefact since the vehicle control in lane 9 (5 µl 70% EtOH) produces the 
same effect as that observed in lane 4 (5 mM Ery in 5 µl 70% EtOH).  It appears that ethanol 





This work reports the first step in determining whether two putative regulator proteins have 
the ability to bind DNA sequences adjacent to the genes they are proposed to regulate.  The 
data obtained showed that the putative transcriptional regulator BLLJ_1496 bound to a region 
of DNA upstream of the three gene operon in which it lies.  This binding occurs in a manner 
similar to that of known MarR-type regulators, where a ‘super-shift’ is often observed when 
the regulator which acts as a dimer binds to two sites in the promoter region (Martin & 
Rosner, 1995).  The observed binding occurred with a strong affinity for the target sequence 
and was not significantly reduced when sodium salicylate, a known inhibitor, was present.  
Binding was also shown to be very specific for the target DNA sequence since no binding is 
observed when other potential DNA targets are presented.  No DNA binding was observed 
for the putative regulator BLLJ_1838 to any of the DNA targets presented.  No conclusions 
can be drawn regarding the function or classification of this protein. 





















Disparity regarding the classification of the putative regulator BLLJ_1496 as a GntR-type 
transcriptional regulator was presented here and even though strong bioinformatic and 
experimental evidence was presented to motivate its re-classification as a MarR-type 
regulator instead, further bioinformatic and experimental analysis proving its function needs 
to be conducted to conclusively prove this.  To confirm its role as a repressor of these ABC-
type transporter genes the regulator protein could be expressed, in trans, with the ABC-type 
transporter genes it is proposed to regulate, in the same host cell.  No resulting increase in the 
MIC to erythromycin and tetracycline would indicate its ability to repress the expression of 
these genes, since, when the ABC-type transporters are expressed in its absence an MDR 
phenotype is observed in L. lactis. 
This data shows the first evidence of a probable MarR-type transcriptional regulator in B. 
longum JCM 1217, which may regulate its own transcription as well as an ABC-type 































Probiotic bacteria are a major constituent of the gut microbiota of both humans and animals.  
Their presence constitutes a positive influence by conferring numerous health benefits to the 
host.  Even though the presence of these bacteria is advantageous, they are known to be 
intrinsically drug resistant and harbour genes coding for ABC-type multidrug efflux systems.  
These systems are beneficial to these bacteria since they confer a competitive advantage 
during antibiotic therapy and also to the host since the bacteria are able to continue providing 
their health benefits during periods of disease.  Regrettably, with the current increase in 
antibiotic resistance in prokaryotes, the possibility of transfer of these genes via HGT cannot 
be ignored.  This study thus aimed to characterise these ABC-type multidrug systems in an 
effort to better understand the ubiquity, range and mechanisms underlying these genes in the 
probiotic bacterium B. longum subsp. longumT JCM 1217. 
 
In Chapter 2 of this study, bioinformatic analysis showed the ubiquity of these types of efflux 
transporters in B. longum JCM 1217, as was highlighted in the membrane protein database.  
Using this database, two putative multidrug efflux systems were identified in the genome of 
B. longum JCM 1217 for further analysis.  These genes exhibited an operon-like structure as 
both clusters were composed of two putative ABC-type transporter genes, as well as, a 
putative transcriptional regulator situated upstream of the two structural genes.  Reverse 
transcriptase PCR experiments showed that these two gene clusters were in fact transcribed 
as two operons; one comprising three genes – inclusive of the putative transcriptional 
regulator, and the other comprising two genes – excluding the putative transcriptional 
regulator.  An interesting outcome of this experiment was the indication of a semi-
quantitative increase in the transcription levels of these genes when the B. longum cells were 
grown in the presence of erythromycin.  These results together showed that these genes do in 
fact not only reside in the genome of B. longum, but also that they are arranged in a manner 















transcription of these genes also appeared to be up-regulated when erythromycin, a known 
substrate of ABC-type transporters, was present.  The clustering of two genes encoding 
different transporter proteins is interesting, as on exposure to antibiotics, cellular resources 
would be minimized since a single transcriptional event is carried out which results in two 
different resistance proteins being produced.  Since these transporters are known to function 
as a homodimer comprising two transporter protein molecules, this would result in a full 
transporter being produced for each transcriptional event, since a number of polypeptides are 
produce for every mRNA transcript produced.  Even though the research to-date has showed 
that these transporters usually function as homodimers, a heterodimer arrangement is 
probable in this case if the two different polypeptides produced are compatible.  This would 
increase the substrate range of the transporter even further as each half-protein, comprising 
one polypeptide, would provide an overlapping, but possibly variant substrate range.  To 
confirm this, assays identifying in vivo protein-protein interactions need to be carried out, and 
should be considered for future work. 
When these ABC-type transporter genes were cloned and heterologously expressed in L. 
lactis cells, they were shown to confer an MDR phenotype on the host by increased resistance 
to erythromycin and tetracycline.  Even though this provides unequivocal proof of the MDR 
resistance function of these genes, further experiments are needed to elucidate the full 
substrate range of each gene under investigation.  An indication of the ATP-dependence of 
these proteins, when active, was also shown using the substrate Hoechst 33342.  These results 
conclusively showed that these genes are functional multidrug resistance genes and when the 
Hoechst 33342 efflux is coupled with the bioinformatic analysis, it presents a strong 
indication that these genes belong to the ATP-binding cassette family of transporters.  
Unfortunately, due to the high background efflux activity in the host L. lactis cells, a 
definitive conclusion regarding their contribution to efflux, could not be established.  Future 
work must, therefore, include experiments aimed at conclusively proving the ATP-
dependence of these genes for active efflux.  This can be accomplished be expressing the 
genes in a systems which lack or are deficient in efflux transporter proteins.  The most 
reliable method would, however, be by expressing these genes in a homologous host system 
where their gene homologues have been deleted.  Any observed increase in the rate of efflux 
would thus be attributable to the expression of the transporter genes, in trans.  Even though 















data to indicate their classification as functional ABC-type multidrug efflux transporter 
genes. 
 
The semi-quantitative induction of these genes observed in the RT-PCR analysis indicated 
their ability to be induced to higher levels of resistance by their exposure to antimicrobial 
substances.  To further investigate this, qRT-PCR experiments were conducted.  These 
experiments showed that when B. longum cells were exposed to sub-lethal concentrations of 
erythromycin, a notable increase in the transcription levels of these genes was observed.  This 
data directly links the transcription of these genes to the observed resistance phenotype in this 
bacterium since these genes are transcriptionally up-regulated in response to erythromycin 
exposure, and confirms the observed MDR phenotype to both erythromycin and tetracycline 
when heterologously expressed in L. lactis cells.  Further experiments are needed to show 
whether this increase in the transcription levels of these genes occurs as a result of the cells’ 
exposure to any antimicrobial substance, or, whether it is in fact due to the presence of 
erythromycin specifically.  This can be accomplished by repeating this experiment with other 
substrates of these efflux genes, as well as, other antimicrobial or toxic compounds.  If the 
response is indeed an antibiotic specific phenomenon, this would highlight the poly-specific 
binding of the transporters for their substrates, which has previously been shown.  The use of 
microarrays can also be used to assay if the observed gene up-regulation is in fact confined to 
these ABC-type transporters in response to antimicrobial exposure, or, whether a more global 
cellular response is initiated. 
 
The influence of a global regulatory mechanism is possible here, since putative 
transcriptional regulators, upstream of each operon, were identified in Chapter 2.  Since all of 
the genes in both operons being studied here are simultaneously up-regulated in response to 
erythromycin exposure, it is probable that a global regulon may be responsible for the 
upregulation of all these resistance genes by simultaneously up-regulating their expression 
through the recruitment of individual gene-specific transcriptional regulators.  This would 
allow for specific and controlled induction of numerous genes to detoxify the cell during 
antibiotic exposure.  The regulator experiments presented in Chapter 4 of this study gives a 
strong indication of not only a gene-specific regulatory mechanism, since both operons being 















also, an indication that they may belong to a global regulatory system, such as the mar 
regulon, since a protein, BLLJ_1496, with a strong homology to proven MarR-type 
transcriptional regulators, was shown to bind specifically and with high affinity, to a DNA 
sequence upstream of the operon of which it is part, in a manner similar to that of other 
proven MarR-type regulator proteins.  Since the data presented here showed that 
erythromycin was not a direct effector molecule of the MarR-type regulator identified, up-
regulation of the levels of gene transcription is probably due to the indirect action of 
erythromycin on another cellular target.  The mar regulon is known to lead to the up-
regulation of multidrug resistance genes in numerous bacteria through the use of MarA, the 
mar activator protein.  This protein is a part of the marRAB locus first identified in E. coli, 
and has been identified as the transcriptional activator of the mar regulon by de-repressing 
binding of marR repressor proteins to their specific DNA sequences (Alekshun & Levy, 
1997; Alekshun & Levy, 1999).  Whether MarA is the transcriptional activator responsible 
for leading to the transcriptional up-regulation of the ABC-type transporter genes identified 
in this study needs to be determined.  No such marA gene homolog has been identified in B. 
longum JCM 1217 and an in-depth bioinformatic analysis is required to identify any potential 
marA homologues.  If such a homolog is indeed identified, it should be functionally 
characterised and its role in de-repressing the MarR-type transcriptional regulator identified 
here should be confirmed. 
 
The work presented in this study elucidates the occurrence of ABC-type MDR genes in a 
probiotic bacterium, which is widely used in industry as a dietary supplement, as well as, a 
culture strain in the food industry.  These genes could potentially afford a competitive 
advantage to the bacterium, and may therefore be exploited as a beneficial characteristic 
when new probiotic strains are selected for use in industry.  The potential for transmission of 
these genes to other gut bacteria cannot be ignored, however, the data presented here gives as 
indication as to the stringent conditions required for heterologous expression of these genes.  
This may indicate the limitation of HGT in a natural setting, since these genes are not easily 
expressed in other commonly used laboratory bacteria such as E. coli.  Future work should 
therefore also look at the dissemination of these genes to other gut bacteria using techniques 

















Figure A2.1. List of putative ABC-type transporters in B. longum NCC2705 at 
http://www.membranetransport.org/ 
Transporter Proteins in Bifidobacterium longum NCC2705 
ATP-Dependent Transporters 
The ATP-binding Cassette (ABC) Superfamily 
PROTEIN 
SUBSTRATE   ABC membrane binding protein 
  BL0064 BL0063* 
 
? 
  BL0154 BL0155 
 
? 
























BL1127 BL1126 ? 
  BL1135 BL1133* 
 
? 
















? (Uup homolog/duplicated ATPase) 
  BL0689 
  
? (Uup homolog/duplicated ATPase) 
  BL1688 
  
? (Uup homolog/duplicated ATPase) 









  BL0043* 
  
cobalt 
  BL0693 BL0694 
 
cobalt 
  BL1070 BL1069 
 
cobalt 
  BL0264 
  
CydD homolog 
  BL0956 BL0955 BL0957 D-methionine 
  BL1677 BL1678? 
 
daunorubicin 





































































































































































*   contains both an ABC and a membrane domain as one polypeptide 
  **   contains both a membrane domain and a binding protein domain as one polypeptide 
   





Figure 2. Results of conserved domain architecture analysis of (A) BLLJ_1837, (B) BLLJ_1836, (C) BLLJ_1495, (D) BLLJ_1494.  The 
blue boxes indicate the ABC membrane superfamily transmembrane region comprising six transmembrane helices.  The pink boxes 
represent the P-loop NTPases family which contains the all the domains required for ATP hydrolyses.  The grey boxes show the MdlB 
domain which encompasses the ABC-type multidrug transport system ATPase and permease components. 
 
Chapter 4 
BLASTP analysis of BLLJ_1496 and BLLJ_1838 against bacterial genomes 
Table A4.1. Top 10 hits of BLASTP search 
BLLJ_1496 as query sequence 

















transcriptional regulator, MarR family [Bifidobacterium breve DSM 
20213] >ref|ZP_07940798.1| MarR family protein [Bifidobacterium sp. 
12_1_47BFAA] >ref|YP_004221255.1| transcriptional regulator 
[Bifidobacterium longum subsp. longum JCM 1217] >gb|EFE88740.1| 
transcriptional regulator, MarR family [Bifidobacterium breve DSM 
20213] >gb|EFV38184.1| MarR family protein [Bifidobacterium sp. 
12_1_47BFAA] 
365 365 100% 5.00E-100 
ZP_04664729.1 
transcriptional regulator [Bifidobacterium longum subsp. infantis CCUG 
52486] >gb|EEQ55440.1| transcriptional regulator [Bifidobacterium 
longum subsp. infantis CCUG 52486] 
365 365 100% 6.00E-100 




transcriptional regulator [Bifidobacterium longum subsp. infantis ATCC 
55813] >gb|EEI80865.1| transcriptional regulator [Bifidobacterium 
longum subsp. infantis ATCC 55813] 




COG1846: Transcriptional regulators [Bifidobacterium longum DJO10A] 
>ref|YP_001955889.1| MarR family transcriptional regulator 
[Bifidobacterium longum DJO10A] 
347 347 100% 3.00E-94 
NP_696912.1 
MarR-type transcriptional regulator [Bifidobacterium longum NCC2705] 
>ref|YP_004001394.1| marr-type transcriptional regulator 
[Bifidobacterium longum subsp. longum BBMN68] 
342 342 100% 7.00E-93 
ZP_03645867.1 
MarR-type transcriptional regulator [Bifidobacterium bifidum NCIMB 
41171] >ref|YP_003938265.1| transcriptional regulator, MarR family 
[Bifidobacterium bifidum S17] 
309 309 100% 4.00E-83 
ZP_07801892.1 
transcriptional regulator [Bifidobacterium bifidum NCIMB 41171] 
>gb|EFR49826.1| transcriptional regulator [Bifidobacterium bifidum 
NCIMB 41171] 
309 309 100% 
6.00E-83 
 
YP_003970605.1 MarR family transcriptional regulator [Bifidobacterium bifidum PRL2010] 274 274 86% 2.00E-72 
ZP_02029901.1 
hypothetical protein BIFADO_02362 [Bifidobacterium adolescentis L2-
32] >gb|EDN82234.1| hypothetical protein BIFADO_02362 
[Bifidobacterium adolescentis L2-32] 
121 121 76% 2.00E-26 
 
 
Table A4.2. Top 10 hits of BLASTP search 
BLLJ_1838 as query sequence 
Accession Description Max Score 
Total 
Score Coverage E-Value 
YP_004209819.1 transcriptional regulator [Bifidobacterium longum subsp. infantis 157F] 222 222 100% 
8.00E-57 
 
YP_004221594.1 transcriptional regulator [Bifidobacterium longum subsp. longum JCM 1217] 221 221 100% 1.00E-56 
ZP_03976952.1 
MarR family transcriptional regulator [Bifidobacterium longum subsp. infantis 
ATCC 55813] >gb|EEI80471.1| MarR family transcriptional regulator 
[Bifidobacterium longum subsp. infantis ATCC 55813] 
218 218 100% 8.00E-56 
ZP_04664129.1 
conserved hypothetical protein [Bifidobacterium longum subsp. infantis CCUG 
52486] >ref|YP_004001056.1| marr-type transcriptional regulator 
[Bifidobacterium longum subsp. longum BBMN68] >gb|EEQ55887.1| conserved 
hypothetical protein [Bifidobacterium longum subsp. infantis CCUG 52486] 
217 217 100% 2.00E-55 




YP_003662205.1 MarR family transcriptional regulator [Bifidobacterium longum subsp. longum JDM301] 216 216 100% 5.00E-55 
NP_695379.1 MarR-type transcriptional regulator [Bifidobacterium longum NCC2705] 214 214 99% 
1.00E-54 
 




transcriptional regulator, MarR family [Bifidobacterium breve DSM 20213] 
>gb|EFE88897.1| transcriptional regulator, MarR family [Bifidobacterium breve 
DSM 20213] 




















Figures A4.1 and A4.2 showing the multiple protein sequence alignments of the top 5 hits 
 
Figure A4.1. Multiple protein sequence alignment of BLLJ_1496 with the top 5 BLASTP hits. 
 
Figure A4.2. Multiple protein sequence alignment of BLLJ_1838 with the top 5 BLASTP hits. 
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